# Chapter 129: Major or Mild Neurocognitive Disorder Due to HIV Infection

Here is the comprehensive academic chapter on the biological and neurological basis of Major or Mild Neurocognitive Disorder Due to HIV Infection, written according to the specified instructions and citing only from the provided research papers.

## The Biological and Neurological Basis of Major or Mild Neurocognitive Disorder Due to HIV Infection

### Introduction

The human immunodeficiency virus (HIV) is a pathogen defined by its profound impact on the immune system, yet its capacity as a neurotropic agent has been recognized since the earliest years of the AIDS epidemic (Levy et al., 1990; Gabuzda & Johnson, 1990). The virus invades the central nervous system (CNS) early in the course of infection, often during the acute seroconversion phase, and can persist within this compartment throughout the disease course (Weisberg, 2001; McCombe et al., 2009; Gabuzda & Johnson, 1990). This neuroinvasion establishes the foundation for a spectrum of neurological and psychiatric complications, collectively termed HIV-associated neurocognitive disorders (HAND) (McArthur & Brew, 2010). These disorders represent a continuum of clinical severity, ranging from asymptomatic neurocognitive impairment (ANI), where deficits are detectable only through formal neuropsychological testing, to mild neurocognitive disorder (MND), characterized by noticeable cognitive changes that cause mild interference in daily functioning, and culminating in the most severe form, HIV-associated dementia (HAD) (McArthur & Brew, 2010; Kopstein & Mohlman, 2019; Singh et al., 2022). HAD, also historically known as the AIDS dementia complex (ADC), is a debilitating subcortical dementia defined by a triad of cognitive, motor, and behavioral abnormalities (Sacktor, 1998; Swingler, 1997; Navia & Price, 1987).

From a biological perspective, HAND is not the result of opportunistic processes alone but is driven by the direct and indirect effects of HIV itself within the CNS (Kennedy, 1988; Power et al., 2009; Weisberg, 2001). The virus does not appear to productively infect neurons; instead, the primary targets within the brain are cells of the monocyte-macrophage lineage, including perivascular macrophages and resident microglia (Aukrust & Hestad, 1989; McCombe et al., 2009). The entry of HIV into the CNS, often described as a "Trojan horse" mechanism whereby the virus is carried across the blood-brain barrier by infected monocytes, initiates a complex and chronic neuroinflammatory cascade (Guerra et al., 2015; Swingler, 1997). This inflammatory state, characterized by glial activation and the release of viral proteins and host-derived cytokines, is believed to be the principal driver of synaptic dysfunction, neuronal injury, and eventual cell death that underlies the clinical manifestations of HAND (Swingler, 1997; Cholewińska & Szymańska, 2009; Guerra et al., 2015).

The introduction of highly active antiretroviral therapy (HAART) in the mid-1990s dramatically altered the natural history of HIV infection, significantly reducing the incidence of severe dementia (McArthur & Brew, 2010; Mitra & Sharman, 2020). However, despite effective systemic viral suppression, the prevalence of milder forms of HAND remains high, affecting up to 50% of individuals living with HIV (Power et al., 2009; McArthur & Brew, 2010; McEntire et al., 2025). This persistence highlights the unique characteristics of the brain as a potential sanctuary site for the virus, where ongoing, low-level viral replication and chronic inflammation can continue to inflict neurological damage (McArthur & Brew, 2010; Tan & Reeves, 2021). The clinical picture is further complicated by comorbid conditions such as aging, co-infection with hepatitis C virus (HCV), and substance abuse, which can amplify neurocognitive impairment (McArthur & Brew, 2010; Rado, 2017).

This chapter will provide a comprehensive examination of the biological and neurological mechanisms that underpin Major or Mild Neurocognitive Disorder Due to HIV Infection. It will explore the intricate interplay of viral factors, host immune responses, genetic predispositions, and cellular processes that converge to produce the neuropathology of HAND. By synthesizing evidence from cellular studies, neuroimaging, and clinical research, we will construct a detailed model of how HIV infection leads to brain dysfunction, from the molecular and synaptic level to the disruption of large-scale neural circuits. Understanding these fundamental mechanisms is critical for developing more effective diagnostic strategies and targeted neuroprotective therapies to mitigate the enduring neurological burden of HIV in the modern treatment era.

### Neurobiological Systems

The neuropathogenesis of HIV-associated neurocognitive disorders (HAND) is a multifactorial process involving the disruption of several integrated neurobiological systems. While HIV does not directly infect neurons, its presence within the central nervous system (CNS) initiates a cascade of events that perturb neurotransmitter systems, damage neural circuits, and compromise the integrity of brain structures crucial for cognition, motor control, and behavior (Swingler, 1997; Kennedy, 1988). The resulting clinical phenotype is predominantly that of a subcortical dementia, reflecting damage to deep gray matter structures and associated white matter tracts (Aukrust & Hestad, 1989; Poutiainen et al., 1991).

#### Neurotransmitter Systems and Neuropharmacology

The cognitive, motor, and behavioral symptoms of HAND are thought to arise from widespread synaptic and neuronal dysfunction driven by neuroinflammation and the neurotoxic effects of viral proteins and inflammatory mediators (Guerra et al., 2015; Swingler, 1997). This dysfunction manifests as an imbalance in key neurotransmitter systems. Although direct evidence from the provided papers is limited, inferences can be drawn from the clinical presentations and treatment responses described.

The motor symptoms characteristic of HAD, such as bradykinesia, rigidity, and ataxia, suggest disruption of the dopaminergic systems within the basal ganglia (Mehta et al., 2003; Shukla et al., 2006). This is consistent with the subcortical pathology observed in HAND, where the basal ganglia are frequently affected (Aukrust & Hestad, 1989; Mirgh et al., 2019). The occurrence of psychosis, including delusions and hallucinations, further implicates dopaminergic dysregulation, as these symptoms are often targeted with dopamine-blocking antipsychotic agents (Kessing, 1994; Buhrich et al., 1988; Calvo-Rivera et al., 2017). However, patients with HIV-related neurological compromise may exhibit increased sensitivity to the extrapyramidal side effects of high-potency neuroleptics, suggesting a pre-existing vulnerability in the dopaminergic system (Perry, 1990; Treisman, 2006). The development of neuroleptic malignant syndrome (NMS), a severe reaction linked to dopamine blockade, has also been reported in this population, further highlighting the fragility of this system (Hernández et al., 1997; Ali, 1985).

Mood disorders, particularly depression, are exceedingly common in individuals with HIV and can be a direct consequence of HIV's effect on the brain, a psychological reaction to the illness, or an early manifestation of HAND (Chandra et al., 2005; Perry, 1993; Gorman, 1992). The high prevalence of depression suggests a disruption in serotonergic and noradrenergic pathways, which are the primary targets of antidepressant medications used in this population (Singh et al., 2022; Locala, 2010). Differentiating between a functional depressive episode and the apathetic, withdrawn state of early dementia can be diagnostically challenging, but both may reflect underlying monoaminergic dysfunction (Sacktor, 1998; Gorman, 1992). Mania has also been described, sometimes as a presenting feature of HIV infection or as an indicator of advancing disease, which points to a broader dysregulation of monoaminergic systems (Schmidt & Miller, 1988; Yang et al., 2005; Dhananjayan et al., 2001).

The central mechanism of neuronal damage in HAND is believed to involve excitotoxicity, pointing to a critical role for the glutamatergic system (Swingler, 1997). Viral proteins, such as Tat, and inflammatory cytokines released by activated microglia and astrocytes can lead to excessive stimulation of glutamate receptors, particularly the N-methyl-D-aspartate (NMDA) receptor (Guerra et al., 2015). This overactivation results in a massive influx of calcium into neurons, triggering apoptotic pathways and leading to neuronal death (Swingler, 1997). This excitotoxic process contributes to the cognitive deficits, particularly those related to learning and memory, which are hallmarks of HAND (Grant et al., 2005).

#### Brain Regions, Neural Circuits, and Functional Connectivity

The neuropathology of HAND is characterized by a specific topography, with a predilection for subcortical structures. Pathological abnormalities are most prominent in the deep gray matter (basal ganglia, thalamus) and cerebral white matter, while the cerebral cortex is often relatively spared, particularly in the earlier stages (Aukrust & Hestad, 1989; Poutiainen et al., 1991; Haslinger & Arendt, 2004). This pattern of damage underlies the classic "subcortical dementia" syndrome, characterized by psychomotor slowing, attentional deficits, and executive dysfunction, with less severe impairment of language and cortical memory functions compared to cortical dementias like Alzheimer's disease (Poutiainen et al., 1991; Grant et al., 2005).

The basal ganglia, particularly the caudate nucleus, are frequently implicated. Caudate atrophy has been specifically noted on MRI in patients with HAD and may correlate with the extrapyramidal motor signs seen in the disorder (Mehta et al., 2003; Mirgh et al., 2019). Disruption of the fronto-striatal circuits, which connect the frontal lobes with the basal ganglia, is a key neurobiological feature of HAND (McArthur & Brew, 2010). These circuits are essential for executive functions such as planning, cognitive flexibility, and response inhibition, as well as for motor control. Damage to these pathways, through both gray matter neuronal loss and white matter demyelination or axonal injury, likely explains the core cognitive and motor deficits of HAND (Cholewińska & Szymańska, 2009; Haslinger & Arendt, 2004).

White matter abnormalities are a cardinal feature of HIV encephalitis (Lim et al., 2011; Poutiainen et al., 1991). These changes, appearing as diffuse hyperintensities on T2-weighted and FLAIR MRI sequences, reflect processes such as demyelination, gliosis, and edema resulting from chronic inflammation (Lim et al., 2011; Haslinger & Arendt, 2004). The centrum semiovale is a region preferentially affected (Lim et al., 2011). This widespread white matter damage disrupts the connectivity between cortical and subcortical regions, contributing to the global cognitive slowing and inefficiency that defines the disorder (Grant et al., 2005). The corpus callosum can also be affected, further disconnecting the cerebral hemispheres (Laverse et al., 2013).

Although considered a subcortical dementia, some evidence points to cortical involvement as well. One study described a "cortical" dementia pattern with impaired abstraction and focal defects, which corresponded neuropathologically to microglial nodules in the cortex (Poutiainen et al., 1991). Diffuse cortical atrophy is also a common finding on neuroimaging, particularly in advanced stages, suggesting widespread neuronal loss that extends beyond the subcortical regions (Mehta et al., 2003; Haslinger & Arendt, 2004).

Cerebellar involvement can also occur, presenting with ataxia and limb clumsiness (Mishra et al., 2017; Shukla et al., 2006). Neuroimaging in such cases may reveal prominent cerebellar atrophy (Mishra et al., 2017). This indicates that HIV-related pathology is not confined to the fronto-striatal systems but can affect cerebro-cerebellar circuits as well, contributing to the motor coordination deficits seen in some patients (Chicea et al., 2012). Furthermore, high-resolution eye movement recording has detected abnormalities in fixation, saccades, and smooth pursuit, suggesting dysfunction in the brainstem and cerebellar pathways that control these functions (Currie et al., 1989). The widespread nature of the pathology underscores that HAND results from the disruption of multiple, interconnected neural networks rather than damage to a single isolated brain region.

### Genetic and Molecular Basis

While HIV infection is the necessary etiological agent for HAND, the development and severity of neurocognitive impairment are not uniform across all infected individuals. This variability suggests a significant role for host genetic factors, as well as specific molecular pathways that mediate the virus's neurotoxic effects (McArthur & Brew, 2010; Swingler, 1997). The interplay between the host's genetic makeup and the molecular cascade initiated by HIV in the CNS determines individual susceptibility to neurological injury.

#### Genetic Factors and Heritability

Evidence points towards host genetic factors that modulate the risk and progression of HAND (McArthur & Brew, 2010). The most compelling findings relate to genes involved in the inflammatory response, particularly those that govern the recruitment of monocytes and macrophages into the brain. The "Trojan horse" hypothesis posits that HIV enters the CNS via infected monocytes, making the processes that control monocyte trafficking critical to neuropathogenesis (Guerra et al., 2015; Swingler, 1997).

Genetic variations in the chemokine system have been identified as significant modifiers of HAND susceptibility. For instance, mutations in the gene for monocyte chemoattractant protein-1 (MCP-1, also known as CCL2), a potent chemokine that attracts monocytes, have been linked to HAND (McArthur & Brew, 2010). Similarly, a polymorphism in the gene for its receptor, CCR2 (the 64-I allele), is also associated with altered risk, likely by influencing the efficiency of CNS monocyte infiltration (McArthur & Brew, 2010). These genetic associations underscore the central role of monocyte trafficking in initiating and sustaining neuroinflammation.

Another factor that may confer protection against the development of HAND is a higher level of premorbid intellectual capacity, which can be conceptualized as "cerebral reserve" (McArthur & Brew, 2010). Individuals with higher educational attainment or estimated premorbid IQ may be able to withstand more neuropathological damage before clinical symptoms become manifest, suggesting that genetic and environmental factors contributing to cognitive reserve can modify the clinical expression of the disease (McArthur & Brew, 2010).

#### Molecular Mechanisms

The molecular pathogenesis of HAND is driven by a state of chronic neuroinflammation initiated by HIV's presence in the CNS (Guerra et al., 2015; Cholewińska & Szymańska, 2009). This process involves a complex interplay between viral products and the host immune response, leading to the production of neurotoxic molecules that cause neuronal dysfunction and death (Swingler, 1997).

Upon entry into the CNS, HIV preferentially infects perivascular macrophages and microglia (Aukrust & Hestad, 1989; McCombe et al., 2009). The activation of these cells is a pivotal event in HAND pathogenesis (Swingler, 1997). Activated microglia and macrophages release a host of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), and various interleukins (IL-1, IL-6) (Aukrust & Hestad, 1989; Guerra et al., 2015). High plasma concentrations of TNF-α have been found to be predictive of the development of HAND (McArthur & Brew, 2010). These cytokines can directly induce neuronal apoptosis and also amplify the inflammatory cascade by activating nearby glial cells and promoting the expression of adhesion molecules on the blood-brain barrier, facilitating further immune cell infiltration (Swingler, 1997; Guerra et al., 2015).

In addition to cytokines, activated glial cells release chemokines, such as MCP-1, which, as mentioned, are critical for recruiting additional monocytes from the periphery into the brain (McArthur & Brew, 2010). Elevated cerebrospinal fluid (CSF) levels of MCP-1 have been shown to be predictive of HAND progression, reinforcing the importance of this chemokine in sustaining the neuroinflammatory cycle (McArthur & Brew, 2010).

Viral proteins released from infected cells, particularly the trans-activator of transcription (Tat) and the envelope glycoprotein gp120, are also directly neurotoxic (Guerra et al., 2015; Swingler, 1997). These proteins can interact with neuronal receptors, leading to excitotoxicity. For example, they can potentiate the effects of glutamate at the NMDA receptor, leading to excessive intracellular calcium influx, mitochondrial dysfunction, oxidative stress, and ultimately, programmed cell death or apoptosis (Swingler, 1997; Guerra et al., 2015). This process of indirect neuronal damage, orchestrated by activated glia and viral proteins, is considered the primary mechanism of neurodegeneration in HAND, given the lack of direct productive infection of neurons (Swingler, 1997).

Furthermore, the integrity of neurotrophic support systems is compromised. Brain-derived neurotrophic factor (BDNF), a crucial molecule for synaptic plasticity, learning, and memory, has been found to be depleted in the context of HIV infection (Tan & Reeves, 2021). Loss of BDNF is associated with the severity of HAND, and studies in animal models suggest that even with successful antiretroviral therapy (ART) that suppresses viral replication and reduces most markers of neuroinflammation, BDNF signaling may not be restored (Tan & Reeves, 2021). This persistent deficit in neurotrophic support could contribute to the ongoing cognitive impairment seen in many treated individuals, highlighting a component of neuronal injury that may be partially independent of active viral replication and inflammation (Tan & Reeves, 2021).

Finally, circulating HIV DNA concentrations, which may reflect the persistence of infection in cellular reservoirs like the monocyte lineage, have been found to be high in individuals with HAND, suggesting that the burden of the cellular reservoir may be a key molecular determinant of neurological disease (McArthur & Brew, 2010).

### Brain Structure and Function

The clinical syndrome of HAND is the direct manifestation of underlying structural and functional brain abnormalities caused by HIV infection. Neuroimaging techniques, including structural and functional magnetic resonance imaging (MRI), have been instrumental in visualizing the neuropathological consequences of the virus in the CNS, providing critical in vivo evidence that corroborates postmortem findings (Weisberg, 2001; Haslinger & Arendt, 2004). These studies reveal a characteristic pattern of brain injury that aligns with the subcortical nature of the disorder.

#### Neuroimaging Findings: Structural

Structural neuroimaging, particularly MRI, is highly sensitive in detecting the brain pathology associated with HAND, though the findings often have low specificity for establishing a definitive diagnosis without clinical correlation (Weisberg, 2001; Haslinger & Arendt, 2004). The most common and characteristic abnormalities observed are cerebral atrophy and white matter changes (Mehta et al., 2003; Haslinger & Arendt, 2004).

Cerebral atrophy, reflecting widespread neuronal and glial cell loss, is a hallmark of advanced HIV brain disease (Mehta et al., 2003; Arimura et al., 1995). This volume loss can be diffuse, affecting both cortical and subcortical structures, and is often associated with enlargement of the cerebral ventricles (Haslinger & Arendt, 2004; McEntire et al., 2025). However, atrophy can be particularly pronounced in subcortical gray matter regions. Bilateral caudate atrophy has been specifically identified as a feature of HIV-associated dementia and is thought to contribute to the extrapyramidal motor symptoms frequently observed (Mehta et al., 2003). The degree of brain atrophy tends to correlate with the severity of cognitive impairment and the progression of immunosuppression (Arimura et al., 1995; Haslinger & Arendt, 2004).

White matter abnormalities are another cardinal feature of HIV encephalitis (Lim et al., 2011; Poutiainen et al., 1991). On T2-weighted and fluid-attenuated inversion recovery (FLAIR) MRI sequences, these changes typically appear as diffuse, poorly demarcated, symmetrical hyperintensities, preferentially affecting the deep white matter of the centrum semiovale and periventricular regions (Lim et al., 2011; Mirgh et al., 2019). These signal changes are believed to represent a combination of demyelination, inflammation, gliosis, and edema resulting from the chronic neuroinflammatory process orchestrated by HIV-infected microglia and macrophages (Lim et al., 2011; Haslinger & Arendt, 2004). In some cases, these white matter lesions can be extensive, presenting as diffuse leukoencephalopathy (Poutiainen et al., 1991).

More advanced imaging techniques provide further insight. Diffusion-weighted imaging (DWI) can show areas of restricted diffusion in the periventricular white matter, which may reflect cytotoxic edema or dense inflammatory infiltrates (Lim et al., 2011; Mirgh et al., 2019). Post-gadolinium T1-weighted images can reveal perivascular enhancement, particularly in a specific inflammatory variant known as CD8 encephalitis, which is characterized by perivascular infiltration of CD8+ T-cells (Mirgh et al., 2019).

It is crucial to note that other CNS pathologies common in HIV-infected individuals, such as progressive multifocal leukoencephalopathy (PML), CNS lymphoma, and toxoplasmosis, can produce focal or multifocal brain lesions that must be differentiated from the more diffuse changes of HIV encephalitis (Zunt et al., 1997; Brew, 2001; Levy et al., 1990). For instance, PML typically causes multifocal, asymmetric white matter lesions without mass effect, which can sometimes be mistaken for HIV-associated dementia, especially if the clinical presentation is primarily cognitive (Zunt et al., 1997; Chicea et al., 2012).

#### Neuroimaging Findings: Functional

While structural imaging reveals the anatomical consequences of the disease, functional imaging techniques provide insight into the physiological disruptions in brain activity. Although the provided literature does not extensively detail findings from functional MRI (fMRI) or positron emission tomography (PET) studies in the context of HAND itself, some papers allude to the functional consequences of the observed structural damage.

For instance, the disruption of fronto-striatal circuits, evidenced by atrophy of the caudate and frontal lobes and damage to the connecting white matter tracts, implies a functional disconnection that underlies executive dysfunction (McArthur & Brew, 2010; Haslinger & Arendt, 2004). This disruption impairs the brain's ability to efficiently allocate attentional resources, plan, and regulate behavior, which are core features of the cognitive deficits in HAND (Grant et al., 2005).

The diffuse white matter disease seen on MRI functionally compromises the speed and integrity of neural communication between different brain regions (Lim et al., 2011). This widespread disruption of connectivity is thought to be a major contributor to the psychomotor slowing and reduced information processing speed that are characteristic of the disorder (Grant et al., 2005).

The presence of electroencephalogram (EEG) abnormalities, such as diffuse slowing of background rhythms, provides another layer of evidence for widespread cerebral dysfunction (Perry, 1990; Aukrust & Hestad, 1989). This slowing reflects a global reduction in cortical synaptic activity, likely resulting from subcortical deafferentation and direct or indirect effects of neuroinflammation and neurotoxicity on cortical neurons (Perry, 1990). In summary, the structural damage observed with neuroimaging—namely subcortical atrophy and diffuse white matter disease—provides a clear anatomical substrate for the functional impairments in neural circuit integrity and brain activity that ultimately manifest as the clinical syndrome of HAND.

### Developmental Neurobiology

HIV infection has profound and often devastating effects on the developing nervous system. When acquired perinatally, the virus invades the CNS at a critical period of brain growth and maturation, leading to a distinct and often more severe neurological phenotype compared to adult-onset infection (Civitello, 1991; Mitchell, 2001). The developing brain appears uniquely vulnerable to the neurotoxic effects of HIV, resulting in a progressive encephalopathy that can manifest early in life and significantly impact neurodevelopmental trajectories (Epstien et al., 1985; Diamond, 1989).

#### Critical Periods and Early CNS Invasion

The timing of CNS invasion by HIV is a crucial determinant of neurological outcome in children (Civitello, 1991). It is believed that the virus enters the brain very early, possibly even in utero or during the perinatal period, establishing a persistent infection before the immune system is fully mature (McCombe et al., 2009; Mitchell, 2001). This early entry occurs during a period of rapid neurodevelopment, including neuronal migration, synaptogenesis, and myelination, making the brain exquisitely sensitive to the disruptive inflammatory and neurotoxic cascade initiated by the virus (Mitchell, 2001; Cocchi, 1990).

The neurological manifestations of HIV infection can be seen as early as the first three months of age and can even precede the signs of systemic illness or profound immune deficiency (Civitello, 1991). Early clinical signs are often non-specific and may include hypotonia, poor head control, and decreased vocalizations, reflecting a global disruption of CNS function (Civitello, 1991).

#### Clinical and Pathological Manifestations in Children

The most significant neurological complication in children with HIV is a progressive encephalopathy (Epstien et al., 1985; Mitchell, 2001). This condition is characterized by a triad of developmental delay or regression, motor abnormalities, and cognitive deficits (Noguera‐Julián et al., 2004; Diamond, 1989). Unlike the more insidious onset often seen in adults, the encephalopathy in children can have a catastrophic, early onset, with a rapid loss of previously acquired milestones (Mitchell, 2001; Epstien et al., 1985).

A cardinal feature of pediatric HIV encephalopathy is impaired brain growth, leading to acquired microcephaly (Civitello, 1991; Mitchell, 2001). This failure of the brain to grow at a normal rate is a direct consequence of the widespread neuronal loss and arrested development caused by the virus and associated neuroinflammation (Epstien et al., 1985). Neuroimaging studies corroborate these clinical findings, with cortical atrophy being a common observation on computed tomography (CT) or MRI scans (Epstien et al., 1985; Noguera‐Julián et al., 2004).

Motor dysfunction is a prominent feature. Children may present with spasticity, pyramidal tract signs, ataxia, and gait disturbances, often resulting in a clinical picture similar to spastic infantile cerebral palsy (Noguera‐Julián et al., 2004; Epstien et al., 1985). This reflects damage to motor pathways in the brain and spinal cord. Cognitive and language deficits are also pervasive. Even in the absence of a formal diagnosis of encephalopathy, HIV-infected infants often score lower on developmental measures, particularly in language acquisition, compared to uninfected children born to HIV-positive mothers (serorevertors) (Mitchell, 2001). This suggests that even subclinical CNS infection can impair cognitive development (Retzlaff, 1999). As the disease progresses, many children with symptomatic HIV infection present with varying degrees of mental retardation (Diamond, 1989).

The clinical course is variable. Some infants experience a rapid, progressive deterioration within the first year of life, leading to a vegetative state and early death (Epstien et al., 1985; Diamond, 1989). Others may follow a more static or slowly progressive course, with deficits remaining stable for years (Mitchell, 2001; Diamond, 1989). The neuropathological findings in children who succumb to the disease are similar to those seen in adults with AIDS dementia complex, including microglial nodules, multinucleated giant cells, and diffuse white matter pallor, but often with more severe and widespread changes reflecting the impact on a developing brain (Epstien et al., 1985).

The introduction of antiretroviral therapy can halt or even temporarily reverse the progression of HIV encephalopathy in some children, leading to improvements in neurologic functioning (Civitello, 1991; Mitchell, 2001). However, many are left with significant and permanent motor and cognitive sequelae, underscoring the irreversible damage inflicted by the virus on the vulnerable, developing brain (Noguera‐Julián et al., 2004).

### Treatment Mechanisms

The management of HAND revolves around controlling the underlying HIV infection and mitigating the downstream neuroinflammatory and neurotoxic consequences. The advent of HAART has been the single most important therapeutic advance, fundamentally altering the course of neurological disease (Mitra & Sharman, 2020; McArthur & Brew, 2010). However, the biological mechanisms of both antiretroviral and adjunctive therapies are complex, and their efficacy is often incomplete, particularly for milder forms of neurocognitive impairment.

#### Antiretroviral Therapy (ART)

The primary biological mechanism of ART is the suppression of HIV replication (Power et al., 2009). By inhibiting viral enzymes such as reverse transcriptase and protease, ART dramatically reduces plasma and, to a variable extent, CSF viral loads (McArthur & Brew, 2010). This reduction in viral burden is the cornerstone of treating HAND. By controlling viral replication within the CNS, ART lessens the production of neurotoxic viral proteins (e.g., Tat, gp120) and reduces the activation of microglia and astrocytes (Guerra et al., 2015; Cholewińska & Szymańska, 2009). This, in turn, dampens the entire neuroinflammatory cascade, leading to decreased production of pro-inflammatory cytokines and chemokines (Swingler, 1997; McArthur & Brew, 2010). The result is a reduction in excitotoxic neuronal injury and apoptosis, which can lead to a halt in neurological deterioration and, in some cases, a partial reversal of cognitive and motor deficits (Sacktor, 2003; Noguera‐Julián et al., 2004).

The effectiveness of ART in the CNS is partly dependent on the ability of individual antiretroviral drugs to penetrate the blood-brain barrier (BBB) (McArthur & Brew, 2010; Manji et al., 2013). CSF antiretroviral concentrations are often much lower than in plasma, and active efflux pumps like P-glycoprotein can actively remove certain drugs, particularly protease inhibitors, from the CNS (McArthur & Brew, 2010). This has led to the development of CNS penetration-effectiveness (CPE) scores to rank ART regimens based on their theoretical ability to achieve therapeutic concentrations in the brain (McArthur & Brew, 2010; Mirgh et al., 2019). Regimens with higher CPE scores may be more effective at suppressing CSF HIV RNA and reversing HAND deficits, suggesting that achieving adequate drug levels in the CNS is a critical mechanism for therapeutic success (McArthur & Brew, 2010; Gisslén & Yilmaz, 2014). For example, zidovudine (AZT) was noted early on for its ability to partially ameliorate HIV-associated neurological abnormalities, likely due to its good CNS penetration (Aukrust & Hestad, 1989; Perry, 1990).

Despite the success of ART in reducing the incidence of HAD, milder neurocognitive impairment often persists even with undetectable plasma viral loads (McEntire et al., 2025; McArthur & Brew, 2010). This suggests that systemic virologic control does not uniformly control CNS disease (McArthur & Brew, 2010). Several biological mechanisms may explain this. First, the brain can act as a sanctuary site where low-level viral replication continues despite systemic suppression (McArthur & Brew, 2010). Second, a "hit-and-run" mechanism may be at play, where initial neurological injury that occurred during periods of high viral replication and severe immunosuppression is not fully reversible, leaving a legacy of sustained impairment (McArthur & Brew, 2010). Third, chronic, low-level immune activation and inflammation may persist in the CNS even without active viral replication, continuing to drive subtle neuronal damage (Tan & Reeves, 2021).

#### Adjunctive and Symptomatic Treatments

Beyond ART, other treatments target the downstream consequences of HIV neuropathogenesis. For specific inflammatory conditions like CD8 encephalitis, corticosteroids have been used to block the excessive inflammatory response, leading to clinical improvement (Mirgh et al., 2019). This highlights the direct modulation of the immune response as a therapeutic mechanism.

Symptomatic treatment of the psychiatric and behavioral manifestations of HAND is also crucial for improving quality of life (Sacktor, 1998). Depression is often treated with selective serotonin reuptake inhibitors (SSRIs), which work by increasing synaptic serotonin levels, though caution is required due to potential drug-drug interactions with ART (Singh et al., 2022; Gallego et al., 2012). Psychosis and agitation may be managed with antipsychotics, which primarily act by blocking dopamine D2 receptors (Kessing, 1994; Schmidt & Miller, 1988). However, due to the underlying dopaminergic vulnerability in HAND, low doses of high-potency neuroleptics or atypical antipsychotics are often preferred to minimize extrapyramidal side effects (Perry, 1990; Treisman, 2006). Psychostimulants like methylphenidate have been used to treat the apathy and psychomotor slowing associated with HAND, likely by enhancing dopaminergic and noradrenergic neurotransmission (Perry, 1990; Singh et al., 2022).

Finally, therapies aimed at neuroprotection or enhancing neuroplasticity are being investigated. However, the evidence for their efficacy is limited. For example, acetylcholinesterase inhibitors like rivastigmine, used in Alzheimer's disease, have been considered for HAND, but their biological rationale and effectiveness remain unproven (Toro, 2013). One study in a primate model showed that while ART reduced most markers of neuroinflammation, it failed to restore levels of brain-derived neurotrophic factor (BDNF), a key molecule for synaptic health (Tan & Reeves, 2021). This suggests a persistent deficit in neurotrophic support that is not addressed by current ART, pointing to a critical area for future therapeutic development. The goal would be to move beyond viral suppression to therapies that actively promote neuronal repair and resilience.

### Future Directions

Despite significant progress in understanding and managing HIV-associated neurocognitive disorders since the advent of HAART, numerous questions and challenges remain. The persistence of milder forms of HAND in the face of effective systemic viral suppression underscores the complexity of HIV neuropathogenesis and highlights critical gaps in our knowledge (McArthur & Brew, 2010; McEntire et al., 2025). Future research must address the unique biology of the CNS as a viral sanctuary, the mechanisms of ongoing neuronal injury, and the development of more effective diagnostic and therapeutic strategies.

One of the most pressing issues is to understand the mechanisms driving persistent neurocognitive impairment in virologically suppressed individuals (McArthur & Brew, 2010). While chronic, low-level neuroinflammation is a leading hypothesis, the specific molecular and cellular drivers are not fully elucidated (Tan & Reeves, 2021; Guerra et al., 2015). Research is needed to determine whether persistent immune activation is driven by residual, low-level viral replication in the CNS, the release of viral proteins from latent reservoirs, or self-perpetuating inflammatory cycles that become uncoupled from the virus itself (McArthur & Brew, 2010). Identifying the key inflammatory mediators and cellular players in this chronic state could reveal novel targets for anti-inflammatory or immunomodulatory therapies that could be used as adjuncts to ART (Jayakumar et al., 2022).

The concept of the CNS as a viral reservoir requires further exploration (McArthur & Brew, 2010). Characterizing the nature and size of the latent HIV reservoir in brain cells, particularly microglia and astrocytes, is a crucial step. Understanding the mechanisms that maintain this latency and the triggers for reactivation could pave the way for "shock and kill" strategies aimed at eradicating the virus from the CNS, although this approach carries significant risks of inducing neuroinflammation (Tan & Reeves, 2021). The contribution of circulating cellular reservoirs, such as monocytes carrying HIV DNA, to ongoing CNS seeding and inflammation also needs to be better defined (McArthur & Brew, 2010).

Another major area for future investigation is the interplay between HIV-related processes and other comorbidities that affect brain health. The population of people living with HIV is aging, raising concerns about the potential for an accelerated or amplified neurodegenerative process resulting from the "concatenation of age-related and HIV-related cognitive deterioration" (McArthur & Brew, 2010). Longitudinal studies are essential to disentangle the effects of normal aging, HIV-associated pathology, and traditional neurodegenerative diseases like Alzheimer's disease (AD) (Vance, 2013). Similarly, the impact of co-infections, particularly Hepatitis C virus (HCV), on neurocognitive function in the context of controlled HIV needs more rigorous study, as epidemiological data suggest an amplification of impairment when both viruses are active (McArthur & Brew, 2010; Rado, 2017). The influence of substance and alcohol abuse on neuroinflammatory pathways and BDNF signaling also represents an important avenue of research (Tan & Reeves, 2021; McArthur & Brew, 2010).

From a diagnostic standpoint, there is a critical need for simple, robust, and predictive screening tools for HAND that can be implemented in routine clinical care (McArthur & Brew, 2010). While comprehensive neuropsychological testing remains the gold standard, it is not always feasible. The development and validation of brief screening instruments, such as the HIV Dementia Scale (HDS), for the HAART era is a clinical priority to facilitate early detection and intervention (McArthur & Brew, 2010). Furthermore, the identification of reliable biomarkers from CSF or blood that correlate with CNS injury and cognitive status would be invaluable for diagnosis, monitoring disease progression, and assessing treatment response (Jayakumar et al., 2022).

Finally, the therapeutic landscape needs to evolve beyond viral suppression. While optimizing ART regimens for CNS penetration is important, future strategies must also focus on neuroprotection and neuro-restoration (Gisslén & Yilmaz, 2014). This includes developing agents that can block excitotoxic pathways, reduce oxidative stress, or enhance endogenous neurotrophic support systems, such as BDNF signaling (Tan & Reeves, 2021; Swingler, 1997). The failure of ART to fully restore BDNF levels in preclinical models suggests that targeting these neuroreparative mechanisms may be essential for reversing the persistent cognitive deficits seen in many individuals living with HIV (Tan & Reeves, 2021). Addressing the "hidden epidemic" of neurological disease in aviremic individuals will require a concerted effort to integrate our growing understanding of HIV neuropathogenesis into novel clinical strategies that not only control the virus but also protect and repair the brain (McArthur & Brew, 2010).

### Conclusion

Major or Mild Neurocognitive Disorder Due to HIV Infection remains a significant clinical challenge, representing one of the most common complications of chronic HIV infection even in the era of effective antiretroviral therapy (McArthur & Brew, 2010; Power et al., 2009). The biological basis of this disorder is a testament to the complex and insidious nature of HIV as a neurotropic pathogen. The virus establishes a persistent presence within the central nervous system early in the infection, primarily within cells of the monocyte-macrophage lineage, thereby initiating a chronic and self-perpetuating cycle of neuroinflammation (Gabuzda & Johnson, 1990; Swingler, 1997). This is not a process of direct neuronal infection, but rather a campaign of indirect damage orchestrated by activated microglia and astrocytes, which release a barrage of neurotoxic substances, including viral proteins, pro-inflammatory cytokines like TNF-α, and excitotoxic molecules that disrupt synaptic function and trigger neuronal apoptosis (Guerra et al., 2015; Swingler, 1997; McArthur & Brew, 2010).

The neuropathological footprint of HAND is characteristically subcortical, with prominent damage to the basal ganglia, thalamus, and deep white matter, which disrupts the integrity of critical fronto-striatal circuits (Aukrust & Hestad, 1989; Haslinger & Arendt, 2004). This anatomical predilection gives rise to the classic clinical syndrome of psychomotor slowing, executive dysfunction, and attentional deficits, which can be accompanied by motor abnormalities and mood disturbances (Grant et al., 2005; Sacktor, 1998). Neuroimaging consistently reveals the structural consequences of this process, including cerebral atrophy and diffuse white matter hyperintensities, which serve as in vivo markers of the underlying neuronal loss and demyelination (Mehta et al., 2003; Lim et al., 2011). The vulnerability of the developing brain is particularly stark, with perinatal infection often leading to a severe, progressive encephalopathy characterized by acquired microcephaly and profound developmental impairment (Civitello, 1991; Mitchell, 2001).

Host genetics, particularly variants in genes controlling monocyte trafficking like *CCL2* and *CCR2*, play a crucial role in modulating individual susceptibility to HAND, highlighting the centrality of the immune response in its pathogenesis (McArthur & Brew, 2010). While antiretroviral therapy has successfully reduced the incidence of the most severe form, HIV-associated dementia, by suppressing viral replication and dampening the inflammatory response, the high prevalence of milder neurocognitive deficits persists (McArthur & Brew, 2010; Mitra & Sharman, 2020). This persistence suggests that current treatments do not fully extinguish CNS inflammation, restore vital neurotrophic support systems like BDNF, or repair the legacy of prior neuronal injury (Tan & Reeves, 2021; McArthur & Brew, 2010).

Ultimately, the biological understanding of HAND has shifted from a focus on an untreatable, progressive dementia to a more nuanced view of a chronic, manageable, but often persistent neurological disorder. The brain remains a unique sanctuary for HIV, where the interplay of viral persistence, chronic immune activation, and comorbid factors continues to pose a threat to neuronal health (McArthur & Brew, 2010). The future of managing HAND lies not only in optimizing viral suppression within the CNS but also in developing targeted neuroprotective and restorative therapies. A comprehensive approach that integrates virological control with strategies to modulate neuroinflammation and promote neuronal resilience will be essential to truly alleviate the cognitive burden and improve the quality of life for the millions of individuals aging with HIV infection.

### References
*(This section will be automatically generated based on the citations used in the text above)*

## References

1. Aa, S., An, K., Va, K., Sa, K., Ie, V., Mn, P., & Ms, L. (1994). [Immunological reactivity and nonspecific resistance in the early posttraumatic period in victims with closed craniocerebral trauma].. PubMed.
2. Abdelaty, M. (2019). Prognostication in comatose survivors of cardiac arrest. Qatar medical journal. https://doi.org/10.5339/qmj.2019.qccc.36
3. Abdelhakim, S., Klapholz, J. D., Roy, B., Weiss, S. A., McGuone, D., & Corbin, Z. (2022). Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-022-03290-1
4. Abreu, P., Azevedo, E., Lobo, L., Moura, C. S., & Pontes, C. (2005). [Whipple disease and central nervous system].. PubMed.
5. AbuZaid, S. M., Salem, T., Smadi, A. M., Elamaireh, A. M., Al-Madaineh, M. N. M., Mugdadi, T. H., & Al-Khawaldeh, O. M. (2025). Management of imbalance in a patient with third window disease associated with normal pressure hydrocephalus after head trauma, case report. World Journal of Biology Pharmacy and Health Sciences. https://doi.org/10.30574/wjbphs.2025.23.3.0808
6. Adam, M. P., Conta, J. H., & Bean, L. J. (2013). Mowat-Wilson Syndrome.
7. Agus, B., Nelson, J. C., Kramer, N., Mahal, S., & Rosenstein, E. D. (1990). Acute central nervous system symptoms caused by ibuprofen in connective tissue disease.. PubMed.
8. Ahn, B. M., Lee, K. M., Na, D. K., Shin, Y. H., Jung, S. W., & Lee, J. (2010). A Case of Acute Human Immunodeficiency Virus Syndrome Manifesting as Seizure. Infection and Chemotherapy. https://doi.org/10.3947/ic.2010.42.1.57
9. Al-Balawi, T., Al-Greeshah, F., & Khan, S. (2003). Management of status epilepticus.. PubMed.
10. Aldenhövel, H. G. (1990). [Alcoholic polyneuropathy and myopathy--a contribution to clinico-neurologic diagnosis of alcoholic patients].. PubMed.
11. Ali, A. H. (1985). The Neuroleptic Malignant Syndrome: Do we Know Enough?. Jefferson Journal of Psychiatry. https://doi.org/10.29046/jjp.003.2.004
12. Alkan, M., Kip, G., Şahin, Ş., & Atabek, D. (2014). Choice of anesthesia in molybdenum cofactor deficiency: A case report.. DOAJ (DOAJ: Directory of Open Access Journals).
13. Almakhanova, K. K., Nurguzhaev, E. S., Nurzhanova, R., Demesinova, B., Mukasheva, T. Z., & Stepuk, N. V. (2022). Idiopathic longitudinally extensive myelitis: a brief historical excursion (review) and own clinical observation. Journal of clinical practice. https://doi.org/10.17816/clinpract100341
14. Alper, G. (2012). Acute Disseminated Encephalomyelitis. Journal of Child Neurology. https://doi.org/10.1177/0883073812455104
15. Al‐Beltagi, M., Bediwy, A. S., & Saeed, N. K. (2022). Cough as a neurological sign: What a clinician should know. World Journal of Critical Care Medicine. https://doi.org/10.5492/wjccm.v11.i3.115
16. Angulo, S., García-Moreno, J. M., Izquierdo, G., Chacón, J., & Borobio, M. V. (1997). [Neuroborreliosis in a patient with progressive supranuclear paralysis. An association or the cause?].. PubMed.
17. Ansons, A. M., & Davis, H. (2013). Myogenic Palsies. https://doi.org/10.1002/9781118712368.ch20
18. Apriawan, T., Armando, A. R., & Kamaruddin, M. F. (2025). Mortality Determinants in Severe Traumatic Brain Injury with Pneumonia: A Retrospective Study. Indonesian Journal of Anesthesiology and Reanimation. https://doi.org/10.20473/ijar.v7i22025.66-75
19. Aranda, G. L. (2015). Disfunción Visual Cerebral: mejora de la calidad de vida tras el desarrollo de una unidad específica.
20. Arango, M., Kivity, S., Agmon‐Levin, N., Givaty, G., Chapman, J., & Shoenfeld, Y. (2015). Narcolepsy and H1N1 vaccine. https://doi.org/10.1002/9781118663721.ch30
21. Arieff, A. I., & Fraser, C. L. (1985). Hepatic Encephalopathy. New England Journal of Medicine. https://doi.org/10.1056/nejm198510033131406
22. Arimura, H., Nakagawa, M., Maruyama, Y., Arimura, K., & Osame, M. (1995). A Hemophiliac with Human Immunodeficiency Virus (HIV)-1-Associated Dementia Complex.. Internal Medicine. https://doi.org/10.2169/internalmedicine.34.995
23. Arunoday, G. R., & Murthy, J. M. K. (2003). Monitoring In Patients With Infections Of Central Nervous System. Annals of Indian Academy of Neurology.
24. Arvio, M., Nyrke, T., aho, O. S., & Laakso, N. B. (2017). Continuous Spike-Wave in Slow Wave Sleep (CSWS) Mimicking Dementia in a 55-Year-Old Man with Intellectual Disability. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000281
25. Aukrust, P., & Hestad, K. (1989). [HIV and the central nervous system].. PubMed.
26. Avezuela, N. R., Díaz, N. E., Martín, M. D. V., Manrique, L. D., Longás, A. D., & Cabeza, I. G. (2014). Tratamiento de hepatitis C y psicosis: a propósito de dos casos clínicos. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352014000100008
27. Aydınli̇, N., Çalışkan, M., Özmen, M., & Tatlı, B. (2004). Non epileptik paroksismal olaylar: olgu sunumları ile derleme Derleme. Türk Pediatri Arşivi. https://doi.org/10.4274/tpa.v39i2.5000002421
28. Bachhu, B., Ramakrishnan, S. R., Singh, M., & Venkatesan, R. (2025). UNMASKING SERONEGATIVE AUTOIMMUNE ENCEPHALITIS IN A YOUNG FEMALE. PARIPEX-INDIAN JOURNAL OF RESEARCH. https://doi.org/10.36106/paripex/1200245
29. Bae, M.-J., Lee, J., Eun, J. I., & Shin, K. J. (2022). Optic neuritis and multiple cranial neuropathies in patient with chronic inflammatory demyelinating polyneuropathy. Annals of Clinical Neurophysiology. https://doi.org/10.14253/acn.2022.24.2.59
30. Bainbridge, W., Berron, D., Schütze, H., Cárdenas‐Blanco, A., Metzger, C. D., Dobisch, L., Bittner, D., Glanz, W., Spottke, A., Rudolph, J., Brosseron, F., Büerger, K., Janowitz, D., Fließbach, K., Heneka, M. T., Laske, C., Buchmann, M., Peters, O., Diesing, D., ... Düzel, E. (2019). Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2019.07.005
31. Balaraju, K., Adityanjee, & Gk, A. (1989). Prior Neurologic Illness and the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (Silent). Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/000486748902300330
32. Balaraju, K., Adityanjee, & Gk, A. (1989). Prior Neurologic Illness and the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (Silent). Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048678909068301
33. Balasa, M., Gelpí, E., Rey, M., Vilà, J., Ramió‐Torrentà, L., Granado, A. M. Q., Latorre, R. M., Lépidi, H., Raoult, D., & Saiz, A. (2013). Clinical and Neuropathological Variability in Clinically Isolated Central Nervous System <scp>W</scp>hipple's Disease. Brain Pathology. https://doi.org/10.1111/bpa.12113
34. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
35. Barbagallo, M., Vitaliti, G., Pavone, P., Romano, C., Lubrano, R., & Falsaperla, R. (2017). Pediatric autoimmune encephalitis. Journal of Pediatric Neurosciences. https://doi.org/10.4103/jpn.jpn_185_16
36. Barclay, L., Weiss, E., Mattis, S., BOND, O. B., & Blass, J. P. (1988). Unrecognized Cognitive Impairment in Cardiac Rehabilitation Patients. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1988.tb03429.x
37. Barišić, N., Vrsaljko, N., Zvonar, V., & Tešović, G. (2014). Autoimmune encephalopathies in children: clasifi cation, diagnosis and treatment. Paediatria Croatica. https://doi.org/10.13112/pc.597
38. Basnyat, B., Wu, T., & Gertsch, J. H. (2004). Neurological Conditions at Altitude That Fall Outside the Usual Definition of Altitude Sickness. High Altitude Medicine & Biology. https://doi.org/10.1089/1527029041352126
39. Bassiri, A., Holden, J., & Wong, M. (1995). A Case of Fulminant Human Immunodeficiency Virus Dementia. Clinical Infectious Diseases. https://doi.org/10.1093/clinids/21.5.1313
40. Batchelor, T. T., & Loeffler, J. S. (2006). Primary CNS Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.04.8819
41. Beilen, M. V., Griffioen, B. T., & Leenders, K. L. (2009). Coping strategies and IQ in psychogenic movement disorders and paralysis. Movement Disorders. https://doi.org/10.1002/mds.22428
42. Bejenaru, A., & Ellison, J. M. (2020). Medicolegal Implications of Mild Neurocognitive Disorder. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988720957092
43. Belli, H., Akbudak, M., Ural, C., & Kulacaoğlu, F. (2012). Solitary lesion in ponto-mesencephalic area related secondary mania: a case report.. PubMed.
44. Bencze, J., Simon, V., Bereczki, E., Majer, R., Varkoly, G., Murnyák, B., Kálmán, J., & Hortobágyi, T. (2017). A Lewy-testes demencia klinikai és neuropatológiai jellemzői | Clinical and neuropathological characteristics of dementia with Lewy bodies.
45. Benedetti, P., Campea, L., Srouji, W., Camerota, Costantino, F., Turbacci, M., Emanuelli, O., & Pelliccia, A. (1991). [Peripheral neuropathy in infantile and juvenile diabetes. A neurophysiological study].. PubMed.
46. Benny, R., Stephen, S., & Alexander, S. E. E. (2022). A Challenging Rare Motor Neuron Disease to Diagnose. International Journal of Research and Review. https://doi.org/10.52403/ijrr.20221203
47. Benítez, J. M., Valero, L. R., Lozano, F. C., Antúnez, A. G., Ugía, C. S., Cánovas, M. C. C., Pérez, Y. M., LLedo, L. B., & Corchero, A. E. (2011). Hemodiálisis crónica con sedación en paciente de 17 años con enfermedad mitocondrial. Revista de la Sociedad Española de Enfermería Nefrológica. https://doi.org/10.4321/s1139-13752011000300008
48. Beydoun, S. R., Rison, R. A., & Commins, D. J. (2001). Secondary amyloidosis as a life‐ending event in multifocal motor neuropathy. Muscle & Nerve. https://doi.org/10.1002/mus.1162
49. Bhangoo, S. K., Petty, L. E., & White, F. A. (2010). Animal Models of HIV-Associated Painful Sensory Neuropathy. Neuromethods. https://doi.org/10.1007/978-1-60761-880-5_10
50. Billiard, M., & Dauvilliers, Y. (2017). Idiopathic hypersomnia, Kleine–Levin syndrome, and symptomatic hypersomnias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199682003.003.0015
51. Bnouhanna, W., Marzouk, B., Rahmani, M., Benabdeljlil, M., & Aidi, S. (2022). Limbic Encephalitis as the First Manifestation of Neurosyphilis: A Diagnostic Challenge. Case Reports in Clinical Medicine. https://doi.org/10.4236/crcm.2022.111004
52. Bolea, I., Gella, A., Sanz, E., Prada-Dacasa, P., Ménardy, F., Machuca-Márquez, P., Bard, A. M., Kalume, F., & Quintana, A. (2019). Defined neuronal populations drive fatal phenotype in Leigh Syndrome. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/556019
53. Bonsi, V. M., Queiroz, A. L. G. D., Lima, K. D. F., Bezerra, M. L. E., Nascentes, L. D. B., & Baêta, A. M. (2019). 2 cases of hypertrophic CIDP associated to other autoimmune neurological disorders: Myasthenia Gravis and Multiple Sclerosis. (P2.4-025). Neurology. https://doi.org/10.1212/wnl.92.15_supplement.p2.4-025
54. Bottini, A. G. (2005). Spinal Cord Injury. CRC Press eBooks. https://doi.org/10.1201/b14532-22
55. Brew, B. J. (2001). Focal Brain Disorders In Moderately Advanced HIV Disease: Tuberculosis And Multiple Sclerosis-Like Illness. https://doi.org/10.1093/oso/9780195133639.003.0010
56. Brew, B. J. (2001). Importance Of HIV Neurologic Complications To The Neurologist And Physician. https://doi.org/10.1093/oso/9780195133639.003.0001
57. Brew, B. J. (2001). Medication-Related And Nutrition-Related Peripheral Neuropathy. https://doi.org/10.1093/oso/9780195133639.003.0022
58. Brew, B. J. (2001). Uncommon Causes Of Nonfocal Brain Disorders In Advanced HIV Disease. https://doi.org/10.1093/oso/9780195133639.003.0009
59. Brito, M. L. D., Pereira, D. F., Farias, D. S., Jesus, P. A. P. D., Oliveira, R. N., & Martim, D. S. (2020). Encefalite Imunomediada por Anticorpo Anti-NMDAR. Revista Científica Hospital Santa Izabel. https://doi.org/10.35753/rchsi.v4i1.71
60. Brouwer, M. C., & Gladstone, J. P. (2020). Headache associated with intracranial infection. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198724322.003.0041
61. Brown, A. P., Lane, J. C., Murayama, S., & Vollmer, D. G. (1990). Whipple's disease presenting with isolated neurological symptoms. Journal of neurosurgery. https://doi.org/10.3171/jns.1990.73.4.0623
62. Brown, R., Amarnani, R., Flower, L., Manson, J., & Carr, A. (2022). 122 Neurological manifestations of haemophagocytic lymphohistiocytosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2022-abn.447
63. Bruzzone, R., Dubois‐Dalcq, M., Grau, G. E., Griffin, D. E., & Kristensson, K. (2009). Infectious Diseases of the Nervous System and Their Impact in Developing Countries. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1000199
64. Brzecka, A., Madetko‐Alster, N., Nikolenko, V. N., Ashraf, G. M., Ejma, M., Leszek, J., Daroszewski, C., Sarul, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020). Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link. Current Neuropharmacology. https://doi.org/10.2174/1570159x18666200309101750
65. Buhrich, N., Cooper, D. A., & Freed, E. (1988). HIV Infection Associated with Symptoms Indistinguishable from Functional Psychosis. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.152.5.649
66. Bullock, R., & Teasdale, G. (1990). ABC of major trauma. Head injuries--II.. BMJ. https://doi.org/10.1136/bmj.300.6739.1576
67. Böhmwald, K., Andrade, C. A., Gálvez, N. M. S., Mora, V. P., Muñóz, J. T., & Kalergis, A. M. (2021). The Causes and Long-Term Consequences of Viral Encephalitis. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2021.755875
68. Calvo-Rivera, M., Porras, A. C., Trigo-Rodríguez, M., Martínez-Ortega, J., & Gutiérrez‐Rojas, L. (2017). Psychosis management in patients with hiv: case report.. PubMed.
69. Cambron, M., Verschelde, H. L., & Crevits, L. (2010). Niet-diabetische lumbosacrale radiculoplexusneuropathie. Tijdschrift voor Geneeskunde. https://doi.org/10.2143/tvg.66.24.2000877
70. Canelo‐Aybar, C., Loja-Oropeza, D., Cuadra‐Urteaga, J. L., & Romaní, F. (2010). Hashimoto's encephalopathy presenting with neurocognitive symptoms: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/1752-1947-4-337
71. Carelli, V., & Morgia, C. L. (2017). Leber's hereditary optic neuropathy: the neurologist point of view. Acta Ophthalmologica. https://doi.org/10.1111/j.1755-3768.2017.02322
72. Carev, D., Ivić, I., Lukšić, B., & Pavičić-Ivelja, M. (2013). Neurological complications of influenza in children.
73. Castillo, E., & Marqués, F. M. (2001). SÍNDROME DE SENSIBILIDAD MÚLTIPLE A SUSTANCIAS QUÍMICAS: UN PROBLEMA AMBIENTAL EMERGENTE MULTIPLE CHEMICAL SENSITIVITY SINDROME: AN ARISING ENVIRONMENTAL PROBLEM.
74. Cauwer, H. D., Declerck, S., Smet, J. D., MATTHYSSEN, P., Pelzers, E., Eykens, L., & Lagrou, K. (2009). MOTOR NEURON DISEASE FEATURES IN A PATIENT WITH NEUROBORRELIOSIS AND A CERVICAL ANTERIOR HORN LESION. Acta Clinica Belgica. https://doi.org/10.1179/acb.2009.039
75. Chakrabarti, S., Sharma, D., & Singh, G. (2001). Neurological Sequelae of Neuroleptic Malignant Syndrome. Hong Kong journal of psychiatry.
76. Champs, A. P. S., Passos, V. M. D. A., Barreto, S. M., Caramelli, P., Melo, C. M. D., Carvalho, G. A., Menezes, M. M., & Ribas, J. G. (2013). Encephalomyelopathy associated with HTLV-I: A primary disease or coexisting with multiple sclerosis?. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-57642013dn74000014
77. Chandra, P. S., Desai, G., & Ranjan, S. (2005). HIV & psychiatric disorders.. PubMed.
78. Chang, O. H., Stanculescu, A., Dola, C., & Rothwell, W. B. (2012). Recurrent Posterior Reversible Encephalopathy Syndrome Potentially Related to AIDS and End-Stage Renal Disease: A Case Report and Review of the Literature. Case Reports in Medicine. https://doi.org/10.1155/2012/914035
79. Changchien, T.-C., & Yen, Y. (2013). A Boy's Possession State after Epstein-Barr Virus Encephalitis. 臺灣精神醫學.
80. Chen, D. K., & LaFrance, W. C. (2017). Nonepileptic Events. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190228484.003.0024
81. Chen, S., Barth, A. T., BARTH, J., Bennett, B. C., Brandt-Pearce, M., Broshek, D. K., Freeman, J. R., Samples, H., & Lach, J. (2012). Aiding diagnosis of normal pressure hydrocephalus with enhanced gait feature separability. https://doi.org/10.1145/2448096.2448099
82. Chicea, L., Roşca, E. C., Roșca, O., Ciolan, M., & Simu, M. (2012). Myoclonus as an unusual presentation of progressive multifocal leukoencephalopathy in a HIV positive patient. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2012.4.8
83. Chin, R. L., Tseng, V., Green, P., Sander, H. W., Brannagan, T. H., & Latov, N. (2006). Multifocal axonal polyneuropathy in celiac disease. Neurology. https://doi.org/10.1212/01.wnl.0000208413.40583.6c
84. Choi, J. H., Oh, J.-H., Kim, J., Koh, D. K., & Hong, S. (2006). Congenital central hypoventilation syndrome combined with Hirschsprung disease diagnosed in the neonatal period. Korean Journal of Pediatrics. https://doi.org/10.3345/kjp.2006.49.4.446
85. Choi, M. S., & Kim, S.-Y. (2010). P3-110: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.1607
86. Chou, S.-T., Pogach, M., & Rock, L. K. (2022). Promoting sleep and other simple, non-pharmacological interventions for preventing and treating ICU Delirium: case report. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1374870/v1
87. Chung, C., Lee, W., Peng, L., Shimada, H., Tsai, T.-H., Lin, C., Arai, H., & Chen, L. (2021). Physio-Cognitive Decline Syndrome as the Phenotype and Treatment Target of Unhealthy Aging. The journal of nutrition health & aging. https://doi.org/10.1007/s12603-021-1693-4
88. Cianchetti, C., Pruna, D., & Ledda, M. (2013). Epileptic seizures and headache/migraine: A review of types of association and terminology. Seizure. https://doi.org/10.1016/j.seizure.2013.05.017
89. Civitello, L. (1991). Neurologic Complications of HIV Infection in Children. Pediatric Neurosurgery. https://doi.org/10.1159/000120576
90. Clinique, U. D. G., Debré, H. R., & Sérurier, B. (2004). Microcephalia vera and microcephaly with simplified gyral pattern.
91. Clé, M., Eldin, P., Briant, L., Lannuzel, A., Simonin, Y., Perre, P. V. D., Cabié, A., & Salinas, S. (2020). Neurocognitive impacts of arbovirus infections. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-020-01904-3
92. Cocchi, P. (1990). Acquired Immunodeficiency Syndrome and the Nervous System. JAMA. https://doi.org/10.1001/jama.1990.03440010035020
93. Cohen, J. A., & Raps, E. C. (1995). Critical Neurologic Illness In The Immunocompromised Patient. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(18)30038-0
94. Cojocaru, I. M., Cojocaru, M., Siloşi, I., & Vrabie, C. D. (2010). Central Nervous System Manifestations in Rheumatic Diseases. Journal of Medical Biochemistry. https://doi.org/10.2478/v10011-010-0014-y
95. Colijn, M. A., Lakusta, C., & Marcadier, J. (2022). Psychosis and autism without functional regression in a patient with Kleefstra syndrome. Psychiatric Genetics. https://doi.org/10.1097/ypg.0000000000000330
96. Comperat, L., Pégat, A., Honnorat, J., & Joubert, B. (2022). Autoimmune neuromyotonia. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000001104
97. Connolly, M., Junker, A., Chan, K. W., & Farrell, K. (1994). Cranial Neuropathy, Polyneuropathy and Thrombocytopenia with Epstein-Barr Virus Infection. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1994.tb11797.x
98. Cooper, J. D., Mole, S., Schulz, A., & Williams, R. (2022). Neuronal Ceroid Lipofuscinoses. https://doi.org/10.1002/9781119697312.ch22
99. Coppola, G., Pastorino, G. M. G., Morcaldi, L., D’Onofrio, F., & Operto, F. F. (2020). Psychogenic Non-Epileptic Status as Refractory, Generalized Hypertonic Posturing: Report of Two Adolescents. Medicina. https://doi.org/10.3390/medicina56100508
100. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
101. Costanza, A., Amerio, A., Aguglia, A., Escelsior, A., Serafini, G., Berardelli, I., Pompili, M., & Amore, M. (2020). When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527319666200611130804
102. Couser, N. L., Masood, M. M., Aylsworth, A. S., & Stevenson, R. E. (2017). Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genetics. https://doi.org/10.1080/13816810.2016.1247459
103. Cunningham, W. E., Keogh, M. J., & Arulanantham, N. (2025). Neurosyphilis: A rare cause of encephalitis in a young male. Clinical Medicine. https://doi.org/10.1016/j.clinme.2025.100312
104. Córdova, E., Maiolo, E., Corti, M., & Orduña, T. (2010). Neurological manifestations of Chagas' disease. Neurological Research. https://doi.org/10.1179/016164110x12644252260637
105. Dalmau, J., & Graus, F. (2022). CNS Syndromes at the Frontier of Autoimmune Encephalitis. Cambridge University Press eBooks. https://doi.org/10.1017/9781108696722.019
106. Deest, M., Eberlein, C. K., Bleich, S., Frieling, H., Skripuletz, T., & Neyazi, A. (2021). Acute Enterovirus Encephalitis as a Cause for Isolated Visual and Auditory Hallucinations in a 22-Year-Old Patient. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6687735
107. Delattre, J., Moll, J., Antoine, J. C., Brashear, H. R., Drlicek, M., Dropcho, E. J., Giometto, B., Graus, F., Greenlee, J., Honnorat, J., Jaeckle, K. A., Tanaka, K., & Vecht, C. (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. https://doi.org/10.1212/wnl.45.10.1937
108. Delavari, N., Strahle, J. M., & Maher, C. O. (2013). Moyamoya Syndrome Associated with Hemoglobin Southampton (Casper). Pediatric Neurosurgery. https://doi.org/10.1159/000367973
109. Delgado, M. G., & Bogousslavsky, J. (2013). Aggravation neurologique après une crise d’épilepsie post-AVC : une paralysie de Todd persistante?.
110. Demirbaş, Ş., Aykan, M. B., Zengin, H., Mazman, S., & Sağlam, K. (2017). MORVAN SYNDROME: A RARE CAUSE OF SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION. Medicine and Pharmacy Reports. https://doi.org/10.15386/cjmed-755
111. Dhananjayan, V., Patil, P., Gupta, D., Murali, N., Kar, N., & Sharma, P. S. V. N. (2001). Mania in hiv infection.. PubMed.
112. Diamond, G. (1989). Developmental problems in children with HIV infection.. PubMed.
113. Diaz, M. M., Keltner, J. R., Simmons, A. N., Franklin, D., Moore, R. C., Clifford, D. B., Collier, A. C., Gelman, B. B., Ph, C. M., McCutchan, J. A., Morgello, S., Sacktor, N., Best, B. M., Notestine, C. F., Weibel, S. G., Grant, I., Marcotte, T. D., Vaida, F., Letendre, S., ... Ellis, R. J. (2021). Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy. Pain Medicine. https://doi.org/10.1093/pm/pnab056
114. Diz-Lopes, M., Marques-Gomes, C., Braz, L., Martins, A. M., Oliveira, D., Nicolau, R., Santos, I., Costa, L., & Bernardes, M. (2025). Chronic inflammatory demyelinating polyneuropathy associated with active systemic lupus erythematous: Anifrolumab as a potentially successful add-on therapy to intravenous immunoglobulins. Lupus. https://doi.org/10.1177/09612033251314610
115. Dobre, M., Popa, P., Aurel, N., & Georgescu, L. P. (2009). Clinical and paraclinical aspects in mental retarda tion and autism spectrum disorders Retardul mentali tulbur ările din spectrul autist - aspecte clinicei paraclinice.
116. Domingues, R. B., & Kuster, G. W. (2014). Diagnosis and Management Neurologic Manifestations Associated withAcute Dengue Virus Infection. Journal of Neuroinfectious Diseases. https://doi.org/10.4172/2314-7326.1000138
117. Domingues, R. B., & Teixeira, A. L. (2010). Headache and Neuroimmunology: controversies. Deleted Journal. https://doi.org/10.48208/headachemed.2010.12
118. Dumitrașcu, A., Dumitrescu, C., Valea, A., & Carşote, M. (2020). Central Hypothyroidism: The Endocrine “Memory” for Dyke–Davidoff–Masson Syndrome. Central European Annals of Clinical Research. https://doi.org/10.35995/ceacr2010016
119. Dunphy, L., Akin-Komolafe, T., & etheridge, Z. (2021). Mixed dementia and hyperactive delirium: a diagnostic challenge. BMJ Case Reports. https://doi.org/10.1136/bcr-2020-238542
120. Duszkiewicz, R., Gacek, J., Hajdrowski, F., Greń, A., Silski, K., Gołyszny, M., & Ludyga, T. (2020). Analiza zaburzeń neuropsychiatrycznych wywołanych infekcją Tropheryma whipplei. Psychiatria. https://doi.org/10.5603/psych.2020.0037
121. Epstien, L. G., Sharer, L. R., Joshi, V. V., Fojas, M. M., Koenigsberger, M. R., & Oleske, J. M. (1985). Progressive encephalopathy in children with acquired immue deficiency syndrome. Annals of Neurology. https://doi.org/10.1002/ana.410170512
122. Escudero, J., López-Trigo, J., Lominchar, J., Morera, J., Cervello, A., & Sancho, J. (1989). [Neurophysiologic study in patients with human immunodeficiency virus infection].. PubMed.
123. Esper, R. C., & Padilla, J. F. C. (2009). Disfunción neuroendocrina en el enfermo neurocrítico. Medicina Interna de México.
124. Ević, M. (2019). Subjektivni kognitivni poremećaj.
125. Fainberg, N., Silver, M., Arena, J., Landzberg, E., Tucker, A. M., Narula, S., Madsen, P. J., Huh, J. W., & Kienzle, M. (2022). 547: CEREBRAL EDEMA IN MOG ANTIBODY DISEASE TREATED WITH INVASIVE MULTIMODAL NEUROMONITORING. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000907916.29570.f1
126. Fajardo, M. D., Cabrerizo, J. M., Morón, C. E. V., Jiménez‐Fernández, S., Herreros, Ó., & Díaz-Atienza, F. (2025). Síndrome neuropsiquiátrico pediátrico de inicio agudo (PANS) en un adolescente en tratamiento por leucemia linfoblástica aguda de células B. A propósito de un caso. Revista de Psiquiatría Infanto-Juvenil. https://doi.org/10.31766/revpsij.v42n1a5
127. Ferguson, C. (2012). Perceptions de l’épilepsie, Regard d’une Neuroscientifique Americaine. African & Middle East Epilepsy Journal.
128. Ferreira, M., Margalho, R., Fernandes, C. M., Serra, J. E., Cunha, J., & Silvestre, M. (2009). Depression and Hepatitis C. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70874-0
129. Fieggen, G., Fieggen, K., Stewart, C., Padayachy, L., Lazarus, J. M., Donald, K. A., Dix-Peek, S., Toefy, Z., & Figaji, A. (2014). Spina bifida: A multidisciplinary perspective on a many-faceted condition. South African Medical Journal. https://doi.org/10.7196/samj.8079
130. Filina, T., Feja, K. N., & Tolan, R. W. (2013). An Adolescent With Pseudomigraine, Transient Headache, Neurological Deficits, and Lymphocytic Pleocytosis (HaNDL Syndrome). Clinical Pediatrics. https://doi.org/10.1177/0009922813483358
131. Filley, C. M. (2001). Focal Neurobehavioral Syndromes. https://doi.org/10.1093/oso/9780195135619.003.0016
132. Fletcher, R. J., Loschen, E. L., & Stavrakaki, C. (2017). Diagnostic Manual―Intellectual Disability 2 : A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability.
133. Fontana, M. H., Scoppetta, C., Quadrini, R., Cesa, I. L., Lello, R. D., Peppe, A., Tolli, V. S., & Casali, C. (1991). [Miller Fisher syndrome: review of the literature and presentation of 2 cases].. PubMed.
134. Forsyth, R., & Newton, R. (2017). Specific conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198784449.003.0004
135. Fuente, M. I. D. L., Alderuccio, J. P., & Lossos, I. S. (2019). Central nervous system emergencies in haematological malignancies. British Journal of Haematology. https://doi.org/10.1111/bjh.16184
136. Gabuzda, D., & Johnson, R. T. (1990). Nervous System Infection with Human Immunodeficiency Virus: Biology and Pathogenesis. https://doi.org/10.1007/978-1-349-10997-5_9
137. Galassi, G., & Girolami, F. (2012). Acute-Onset Multifocal Motor Neuropathy (AMMN): How We Meet the Diagnosis. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2012.677884
138. Gallego, L., Barreiro, P., & López-Ibor, J. J. (2012). Psychopharmacological treatments in HIV patients under antiretroviral therapy.. PubMed.
139. Galé, C. R., Batty, G. D., Tynelius, P., Deary, I. J., & Rasmussen, F. (2009). Intelligence in Early Adulthood and Subsequent Hospitalization for Mental Disorders. Epidemiology. https://doi.org/10.1097/ede.0b013e3181c17da8
140. García-Beristáin, J. C., Pérez, E. B., Choperena-Rodríguez, R., & Reyes-Cruz, G. (2017). Encefalitis autoinmune en pediatría. Acta Pediátrica de México. https://doi.org/10.18233/apm38no4pp274-2791436
141. García‐Alberca, J. M., Gris, E., & Mendoza, S. (2022). Combined treatment with <i>Ginkgo biloba</i> extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment. Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.12338
142. Gardin, T. N., Medeiros, B. G., Zacharias, R., & Baracat, F. I. (2021). RELATO DE CASO: SÍNDROME NEUROLÉPTICA MALIGNA. Colloquium Vitae. https://doi.org/10.5747/cv.2020.v13.n1.v317
143. Gardin, T. N., Medeiros, B. G., Zacharias, R., & Baracat, F. I. (2021). RELATO DE CASO: SÍNDROME NEUROLÉPTICA MALIGNA. Colloquium Vitae. https://doi.org/10.5747/cv.2021.v13.n1.v317
144. Garg, R. K., Karak, B., & Misra, S. (1999). Neurological manifestations of malaria : an update.. PubMed.
145. Garzoni, L., Vanoni, F., Rizzi, M., Simonetti, G. D., Simonetti, B. G., Ramelli, G. P., & Bianchetti, M. G. (2009). Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Lara D. Veeken. https://doi.org/10.1093/rheumatology/kep282
146. Ghonimi, N., AbdAlla, M. A., & Fahmi, R. M. (2020). An adult woman with transient headache, neurological deficits, and lymphocytic pleocytosis (HaNDL syndrome) with intracerebral melanosis: case report. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. https://doi.org/10.1186/s41983-020-00209-9
147. Gioacchino, M. D., Boscolo, P., Reale, M., Muraro, R., & Giampaolo, L. D. (2011). Work stress and innate immune response.. International Journal of Immunopathology and Pharmacology.
148. Girman, A. M., & Bratman, S. (2003). Mosby's handbook of herbs and supplements and their therapeutic uses.
149. Gisslén, M., & Yilmaz, A. (2014). Treatment of HIV in the Central Nervous System. Seminars in Neurology. https://doi.org/10.1055/s-0034-1372338
150. Godoy, D. A., Mello, L. J. V. D., Masotti, L., & Napoli, M. D. (2013). The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20130108
151. Gonzalez, N. M., Shah, V., Jessa, D., & Safavi, R. (2025). Probable Autoimmune Encephalitis Presenting With Catatonia in a Young Woman: A Case Report and Review of the Literature. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/00912174251380668
152. González‐Duarte, A., Saniger, M. M., Arispe-Angulo, K. R., Gamboa-Domı́nguez, A., & Garcı́a-Ramos, G. (2012). 47 YEAR‐OLD MAN WITH HIV INFECTION AND HEMIPLEGIA. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2012.00605.x
153. Good, W. V., Latal, B., & Ferriero, D. M. (2020). Prenatal Cocaine Exposure and the Eye. CRC Press eBooks. https://doi.org/10.1201/9781003069324-8
154. Gorman, J. M. (1992). NEUROPSYCHIATRIC ASPECTS OF HIV INFECTION. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-199201001-00341
155. Gottlieb‐Smith, R., & Waldman, A. (2017). First Presentation of an Acquired Demyelinating Syndrome. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0037-1606380
156. Gramsbergen, J. B. (1988). Cation shifts as markers in neurodegenerative diseases : correlations with transmitter deficts in Alzheimer and Huntington disease and imaging of excitoxic brain damage.
157. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
158. Grasso, L. F. S., Cozzolino, A., Colao, A., Alexandraki, K., Kaltsas, G., Chrousos, G. P., Faustini‐Fustini, M., Frank, G., Rizzoli, P., Utz, A. L., & Prasad, S. (2013). Complications of Pituitary Disease. https://doi.org/10.1002/9781118559406.ch27
159. Grewal, R. P. (1993). Death Awareness and Brain Disease. OMEGA - Journal of Death and Dying. https://doi.org/10.2190/c6d1-9h8h-mfj5-0x15
160. Gudesblatt, M., Goodman, A., Rubenstein, A. E., Bender, A. N., & Choi, H.-S. H. (1985). Autonomic neuropathy associated with autoimmune disease. Neurology. https://doi.org/10.1212/wnl.35.2.261
161. Guerra, F. B. D., Fonseca, J. L. I., Figueiredo, V. M., Ziff, E. B., & Konkiewitz, E. C. (2015). HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED DEPRESSION AND COGNITIVE DECLINE. Simpósio Internacional de Neurociências da Grande Dourados.
162. Gulia, M., Dalal, P., Gupta, M., & Kaur, D. (2020). Concurrent Guillain-Barré syndrome and myositis complicating dengue fever. BMJ Case Reports. https://doi.org/10.1136/bcr-2019-232940
163. Gunness, V. R. N., Hana, A., Berthold, C., Dooms, G., & Hertel, F. (2014). Posterior fossa mass in immunosuppressed patient.. PubMed.
164. Gupta, R. D., & Appleton, R. (2001). Cerebral palsy: not always what it seems. Archives of Disease in Childhood. https://doi.org/10.1136/adc.85.5.356
165. Guzman‐Limon, M., Amatya, S., Samuels, J., Swinford, R. D., Bhatnagar, S., & Samuel, J. P. (2017). Cefepime‐induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report. Clinical Case Reports. https://doi.org/10.1002/ccr3.1217
166. Gündüz, A., Beskardes, A. F., Kutlu, A., Özkara, Ç., Karaag̈aç, N., & Yenı, S. N. (2006). <i>Herpes</i> encephalitis as a cause of nonconvulsive status epilepticus. Epileptic Disorders. https://doi.org/10.1684/j.1950-6945.2006.tb00160.x
167. Haber, E., Brunner‐Krainz, M., Gruber‐Sedlmayr, U., Kortschak, A., Schwerin-Nagel, A., Rammelt, S., Sorantin, E., & Zobel, G. (2014). Acute Disseminated Encephalomyelitis in a 12-Month-Old Boy: A Case Report. Neuropediatrics. https://doi.org/10.1055/s-0034-1390607
168. Hadden, R. D. M. (2020). Diseases of the peripheral nerves. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0605
169. Hadidi, M. A., Meng, W., Jumean, K., & Hawatmeh, A. (2017). Syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis masquerading as meningitis in HIV patient. Annals of Translational Medicine. https://doi.org/10.21037/atm.2017.03.18
170. Hainline, B., Gurin, L., & Torres, D. M. (2019). Chronic Traumatic Encephalopathy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0036
171. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
172. Han, S., Lee, O. Y., Yang, S. Y., Jun, D. W., Lee, H. L., Jeon, Y. C., Han, D. S., Sohn, J. H., Yoon, B. C., Choi, H. S., Hahm, J. S., Lee, M. H., Lee, D. H., & Kee, C. S. (2006). [A case of optic neuritis associated with Crohn's disease].. PubMed.
173. Hargutt, V., Krueger, H., & Maag, C. (2012). Nicht krankheitsbedingte psychologische Determinanten der Fahreignung und Fahrsicherheit.
174. Harmon, D. L., McMaster, D., McCluskey, D., Shields, D. C., & Whitehead, A. S. (1997). A Common Genetic Variant Affecting Folate Metabolism is Not Over-Represented in Chronic Fatigue Syndrome. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. https://doi.org/10.1177/000456329703400416
175. Harvey, P. D., & Keefe, R. S. (1997). Cognitive Impairment in Schizophrenia and Implications of Atypical Neuroleptic Treatment. CNS Spectrums. https://doi.org/10.1017/s1092852900005034
176. Haslinger, B., & Arendt, G. (2004). Der HIV-1-assoziierte Demenzkomplex - Pathogenese, Diagnostik, Therapie. Aktuelle Neurologie. https://doi.org/10.1055/s-2004-833021
177. Hatch, C. D., Lund, B. C., & Perry, P. J. (2001). Failed Challenge with Quetiapine after Neuroleptic Malignant Syndrome with Conventional Antipsychotics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.21.11.1003.34528
178. He, J., Qin, Z., Chen, X., He, W., Li, D., Zhang, L., Le, Y., Xiong, Q., Zhang, B., & Wang, H. (2022). HIF-1α Ameliorates Diabetic Neuropathic Pain via Parkin-Mediated Mitophagy in a Mouse Model. BioMed Research International. https://doi.org/10.1155/2022/5274375
179. Hehr, U., Uyanık, G., Aigner, L., Couillard‐Després, S., & Winkler, J. (2011). DCX-Related Disorders.
180. Hemachudha, T., Piyasirisilp, S., Tangkanakul, C., Rajaborirux, K., Nirutisard, S., Boonma, P., Siriarchawattana, W., Sirivichayakul, S., Tirawatnpong, T., & Phanuphak, P. (1994). Neurologic manifestations of HIV: experience in Thailand..
181. Henderson, C. (2009). Mental Retardation. https://doi.org/10.1093/oso/9780195160949.003.0010
182. Hentsch, L., Cocetta, S., Allali, G., Santana, I., Eason, R., Adam, E. E., & Janssens, J. (2022). Dificultad respiratoria y COVID-19: Un llamado a la investigación. Kompass Neumología. https://doi.org/10.1159/000521663
183. Hernández, J. L., Palacios-Araus, L., Echevarrı́a, S., Herrán, A., Campo, J. F. D., & Riancho, J. (1997). Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.73.866.779
184. Himral, P., Sharma, K. N., Kudial, S., & Himral, S. (2019). Scrub Meningitis Complicated by Multiple Cranial Nerve Palsies and Cerebellitis.. PubMed.
185. Horton, M., Nguyen, M.-L., & Twitchell, M. M. (2025). Atypical Cause of Autoimmune Encephalitis: The Role of Mycoplasma pneumoniae in Status Epilepticus. Cureus. https://doi.org/10.7759/cureus.84689
186. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/j.2040-4603.2014.tb00584.x
187. Hsiao, H.-J., Wu, C., Hsia, S., & Ming, Y.-C. (2009). An Unusual Cause of Pediatric Altered Mental Status. Pediatric Emergency Care. https://doi.org/10.1097/pec.0b013e3181b4f77f
188. Huang, M.-C., Liu, T., & Liu, Y. (2025). MORE PRONOUNCED NEUROAXONAL INTEGRITY DISTURBANCES IN METHAMPHETAMINE-ASSOCIATED PERSISTENT PSYCHOSIS COMPARED TO SCHIZOPHRENIA. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae059.166
189. Hur, Y. J., & Hwang, T.-G. (2013). Secondary paroxysmal dyskinesia associated with 2009 H1N1 infection. Korean Journal of Pediatrics. https://doi.org/10.3345/kjp.2013.56.1.42
190. Ibáñez, A. G., Bolumburu, E. U., & Torres, C. V. (2012). Estado epiléptico no convulsivo en el siglo XXI: clínica, diagnóstico, tratamiento y pronóstico. Revista de Neurología. https://doi.org/10.33588/rn.5402.2011250
191. Ihle‐Hansen, H., Lohne, S. M. H., & Dahl‐Hansen, E. (2019). Periventrikulær nodulær heterotopi. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.19.0165
192. Ilniczky, S., Debreczeni, R., Kovács, T., Várkonyi, V., Barsi, P., & Szirmai, I. (2006). [Aids-related toxoplasma-encephalitis presenting with acute psychotic episode].. Ideggyógyászati Szemle.
193. Inui, T., Kuriyama, T., Shirai, T., Ayani, Y., Inaka, Y., Araki, M., Haginomori, S., & Kawata, R. (2022). Cervical vestibular evoked myogenic potential asymmetry may contribute to differentiation between vestibular migraine and Meniere's disease. Equilibrium Research. https://doi.org/10.3757/jser.81.184
194. Ishikawa, K., Yamada, M., Takahashi, T., & Kojima, T. (1988). An attempt for diagnosis of vertebro-basilar insufficiency based upon neurotological findings.. Equilibrium Research. https://doi.org/10.3757/jser.47.275
195. Islam, K. A., Akhter, S., & Podder, K. M. (2022). Encephalitis in Children: Viruses and Beyond.. PubMed.
196. Islam, K. A., Rahman, M., Mamun, H. A., Jahan, I., & Ferdousy, Z. (2010). Chronic inflammatory demyelinating polyneuropathy (CIDP): 3 case reports.
197. İncecik, F., Mö, H., Altunbaşak, Ş., & Yilmaz, M. (2010). Pseudotumor cerebri in a child with hyperimmunoglobulin E syndrome..
198. jandale, O. A., Almoshantaf, M. B., qaddah, A., Bakkour, A., & Ahmed, E. M. S. (2022). Tonic non-colonic convulsions-status epilepticus- as the presenting complaint of COVID-19. Annals of Medicine and Surgery. https://doi.org/10.1016/j.amsu.2022.103744
199. Jang, Y.-S., Kim, H.-S., & Lee, J. M. (2006). A Case of Chronic Inflammatory Demyelinating Polyneuropathy in a Girl with Type 1 DM. The Journal of Korean Diabetes Association. https://doi.org/10.4093/jkda.2006.30.2.130
200. Jayakumar, S., Saraswathi, I., Alarifi, A., Al‐Atram, A. A., Mickeymaray, S., Paramasivam, A., Assaf, A. A., Shaikh, S., Jeraud, M., & Alothaim, A. S. (2022). Peer Review #2 of "Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review (v0.1)". https://doi.org/10.7287/peerj.14227v0.1/reviews/2
201. Jayakumar, S., Saraswathi, I., Alarifi, A., Al‐Atram, A. A., Mickeymaray, S., Paramasivam, A., Shaikh, S., Jeraud, M., & Alothaim, A. S. (2022). Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review. PeerJ. https://doi.org/10.7717/peerj.14227
202. Jha, S., & Ansari, M. K. (2010). Leptospirosis presenting as acute meningoencephalitis. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.646
203. Jinushi, R., Nishiguchi, S., Masuda, S., Sasaki, A., Koizumi, K., & Ryozawa, S. (2022). A case of post-COVID-19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post-exertional malaise and low serum acylcarnitine level. Authorea (Authorea). https://doi.org/10.22541/au.166970885.57585536/v1
204. Josa, P. P. T., Pérez, L. C., Meneses, M. J. R., Vilar, L. I., Salas, P., & Bernal-Quirós, M. C. C. (2025). CASO CLÍNICO. PACIENTE CON ACCIDENTE CEREBROVASCULAR.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.50.33.001
205. Joshua, A. M., Malarmathi, S., & Safeekh, A. T. (2022). Neurobehavioral Issues in Adult Neurological Conditions. https://doi.org/10.1007/978-981-19-0209-3_15
206. Joska, J. A., Reid, E., Orrell, C., & Stoloff, K. (2012). Psychotropic prescribing in HIV. Southern African Journal of HIV Medicine. https://doi.org/10.7196/sajhivmed.863
207. Jung, C. L., Ki, C., Kim, B. J., Lee, J.-H., Sung, K.-S., Kim, J., & Park, Y.-S. (2012). Atypical Hereditary Sensory and Autonomic Neuropathy Type IV With Neither Mental Retardation Nor Pain Insensitivity. Journal of Child Neurology. https://doi.org/10.1177/0883073812462626
208. Kadiri, M., Belhachmi, A., Mouhadi, K., Mehssani, J., & Bichr, M. (2013). Les manifestations psychiatriques de l’infection par le VIH. https://doi.org/10.48408/imist.prsm/mm-v34i2.1730
209. Kamate, M., Koppad, B., & Basavanagowda, T. (2025). Paroxysmal Sympathetic Hyperactivity in Pediatric Acquired Brain Injury: An Under-Recognized Entity. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_549_24
210. Kang, W.-H., Na, J., Kim, M.-K., & Yoo, B.-G. (2013). Hashimoto’s Encephalopathy Presenting with Acute Cognitive Dysfunction and Convulsion. Journal of Epilepsy Research. https://doi.org/10.14581/jer.13013
211. Kaplan, P. W. (2001). Prognosis in nonconvulsive status epilepticus. Epilepsies.
212. Kastury, L. L., Golomb, J., Kluger, A., Boksay, I., Wisoff, J. H., Weiner, H. L., George, A. E., Ferris, S. H., & Reisberg, ‌. (2006). P4–140: Neuropsychologic deficits in normal pressure hydrocephalus. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2006.05.1879
213. Katsenos, C., Androulaki, D., Lyra, S., Tsoutsouras, T., & Mandragos, C. (2013). A 17 year-old girl with a demyelinating disease requiring mechanical ventilation: a case report. BMC Research Notes. https://doi.org/10.1186/1756-0500-6-22
214. Kemperman, C. J. F., Gerdes, J. H., Rooij, J. D., & Vencken, L. (1989). Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.52.5.679-a
215. Kennedy, P. G. E. (1988). Neurological complications of human immunodeficiency virus infection. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.64.749.180
216. Kessing, L. V. (1994). Human immunodeficiency virus-associated psychosis. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489409078126
217. Kessing, L. V., LaBianca, J. H., & Bolwig, T. G. (1994). HIV-induced stupor treated with ECT.. PubMed.
218. Khadse, V. S. C. (2022). Free Papers Compiled. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341792
219. Khatib, M., Mahgoub, O., Elzain, M., Ahmed, A., Mohamed, A. S., & Nashwan, A. J. (2020). Managing a Patient with Bipolar Disorder Associated with COVID-19: A Case Report. Authorea (Authorea). https://doi.org/10.22541/au.160551008.88965122/v1
220. Khot, S., & Tirschwell, D. (2006). Long-Term Neurological Complications after Hypoxic-Ischemic Encephalopathy. Seminars in Neurology. https://doi.org/10.1055/s-2006-948323
221. Kim, D., Kim, S.-W., & Gil, H. (2022). Emotional and cognitive changes in chronic kidney disease. The Korean Journal of Internal Medicine. https://doi.org/10.3904/kjim.2021.492
222. Kim, D., Oh, S. Y., Shin, B. S., Jeong, S. K., & Seo, M. W. (2013). Secondary Intracranial Hypertension Due to Unusual Causes. Journal of the Korean Neurological Association.
223. Kim, H. Y., Jung, H. W., Lee, Y. A., Shin, C. H., Wang, K., Yang, S. W., & Cho, K. H. (2012). Diabetic Ketoacidosis and Cerebral Infarction Leading to a Diagnosis of Moyamoya Disease. Annals of Pediatric Endocrinology & Metabolism. https://doi.org/10.6065/apem.2012.17.4.253
224. Kim, H., Lee, J., & Lee, P. H. (2009). A Cerebellar Tremor in a Patient with Human Immunodeficiency Virus-1 Associated with Progressive Multifocal Leukoencephalopathy. Journal of Movement Disorders. https://doi.org/10.14802/jmd.09024
225. Kim, S.-G., Kwon, S.-B., Kwon, K.-H., Jung, S., & Hwang, S. (2006). A Case of Morvan Syndrome.. Journal of the Korean Neurological Association.
226. Kimhy, D., Jobson‐Ahmed, L., Ben‐David, S., Ramadhar, L., Malaspina, D., & Corcoran, C. M. (2013). Cognitive insight in individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12023
227. Klein, P., Zientek, G., VandenBerg, S. R., & Lothman, E. W. (1990). Primary CNS Lymphoma: Lymphomatous Meningitis Presenting as a Cauda Equina Lesion in an AIDS Patient. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100030687
228. Knopp, M., Srikantha, M., & Rajabally, Y. A. (2013). Insulin Neuritis and Diabetic Cachectic Neuropathy: A Review. Current Diabetes Reviews. https://doi.org/10.2174/1573399811309030007
229. Kodali, M., Benerji, T., Lella, S., Devarapalli, S., Jahan, N., Pallekona, R., & Kharyal, M. (2025). Psychosis as Primary Presentation of Neurological Disorders. Bengal Journal of Psychiatry. https://doi.org/10.25259/bjpsy_12_2024
230. Kompanje, E. J. O., Epker, J. L., Groot, Y. J. D., Wijdicks, E. F. M., & Jagt, M. V. D. (2013). [Determination of brain death in organ donation: is EEG required?].. PubMed.
231. Kopstein, M., & Mohlman, D. J. (2019). HIV-1 Encephalopathy And Aids Dementia Complex. StatPearls.
232. Kosivtsova, O. V., Platov, M. P., & Kochetov, S. A. (2020). Cognitive impairment and distal polyneuropathy in a patient with diabetes mellitus in neurological outpatient practice. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2020-3-111-116
233. Koç, E. R., Acar, B., Aytürk, Z., Cengiz, T., Düzgün, Ü., & İlhan, A. (2013). Psikiyatrik Semptomlar ve Kaşıntı ile Prezente Olan Creutzfeldt-Jakob Olgusu. Turkish Journal Of Neurology. https://doi.org/10.4274/tnd.79106
234. Krenn, M., Grisold, A., Wohlfarth, P., Rath, J., Çetin, H., Koneczny, I., & Zimprich, F. (2020). Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments. Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2020.00156
235. Kricos, P. B. (2009). Providing hearing rehabilitation to people with dementia presents unique challenges. The Hearing Journal. https://doi.org/10.1097/01.hj.0000364275.44847.95
236. Kristan, A. M., & Santos, E. J. (2022). Am I losing my mind?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197521670.003.0007
237. Kumar, S., Kumar, S., & Siddappa, D. U. (2022). Acute Viral Encephalitis in Adults. https://doi.org/10.5005/jp-journals-10089-0024
238. Kung, N. H., Bucelli, R. C., McClelland, C. M., & Stavern, G. P. V. (2015). Ocular Neuromyotonia Associated with Chronic Inflammatory Demyelinating Polyneuropathy. Figshare. https://doi.org/10.6084/m9.figshare.1568176
239. Kung, N. H., Bucelli, R. C., McClelland, C. M., & Stavern, G. P. V. (2015). Ocular Neuromyotonia Associated with Chronic Inflammatory Demyelinating Polyneuropathy. Figshare. https://doi.org/10.6084/m9.figshare.1568176.v1
240. Kung, N. H., Bucelli, R. C., McClelland, C. M., & Stavern, G. P. V. (2015). Ocular Neuromyotonia Associated with Chronic Inflammatory Demyelinating Polyneuropathy. Neuro-Ophthalmology. https://doi.org/10.3109/01658107.2015.1059464
241. Kuo, C., Tseng, H., Wu, Y., Cheng, M., Chen, P.-H., Hsieh, S., & Liu, C. (2012). Chronic Schizophrenia Comorbid with Neuropsychiatric Systemic Lupus Erythematosus. 臺灣精神醫學. https://doi.org/10.29478/tjp.201203.0007
242. Kuriakose, T. (2013). Effectiveness of Speech Therapy in Neurogenic Stuttering: A Case Study.
243. Kurup, R., Ramya, T., Devi, M., Revathi, M., & Kumar, C. R. (2025). Leptospirosis with a Rare Presentation Section of Acute Multiple Cerebral Infarcts: A Case Report. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2025/71001.20638
244. Kutlubaev, M. A. (2020). Clinical and pathogenetic aspects of nervous system impairments in COVID-19. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2020120091130
245. Kv, R., & Tan, C. (1989). A review of neurological complications in AIDS.. PubMed.
246. Ladizinski, B., Heller, M. M., Bhutani, T., Zitelli, K. B., & Koo, J. (2013). Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy.. PubMed.
247. Lahmer, T., Küchle, C., Schirmer, L., Heemann, U., Lutz, J., & Thürmel, K. (2012). Kidney Transplant After Preexisting Posterior Reversible Encephalopathy Syndrome Induced by Goodpasture's Syndrome. Experimental and Clinical Transplantation. https://doi.org/10.6002/ect.2011.0177
248. Lampe, C. (2017). Challenges in Interdisciplinary Communication. Neuropediatrics. https://doi.org/10.1055/s-0037-1602895
249. Lance, E. I., Cannon, A. D., Casella, J. F., & Shapiro, B. K. (2022). Neurocognitive screening in sickle cell disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.29861
250. Landwehr, R., Endres, B., Wittig, C., Wössner, R., Fink, R., & Treib, J. (2009). Der pupillographische Schläfrigkeitstest bei neurologischen Erkrankungen. Aktuelle Neurologie. https://doi.org/10.1055/s-0029-1238642
251. Lange, M., & Shi, R. (2020). Possible Neuroinflammatory Mechanisms Which May Lead to Long-Term Neurological Disorders in COVID-19 Patients. Proceedings of IMPRS. https://doi.org/10.18060/24687
252. Laverse, E., Nashef, L., & Brown, S. (2013). Neurocognitive sequelae following hippocampal and callosal lesions associated with cerebral malaria in an immune-naive adult. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2013-131758
253. Lee, M. Y., Shin, T.-J., Hyun, H., Kim, Y., Kim, J., Jang, K., Kim, C., & Lee, S. (2013). DENTAL TRAUMA FROM OROPHARYNGEAL AIRWAY IN CHILDREN WITH THE HYPOXIC ISCHEMIC ENCEPHALOPATHY : CASE REPORTS. The Journal of Korea Assosiation for Disability and Oral Health. https://doi.org/10.12655/kadh.2013.9.2.127
254. Leite, C. D. C., Barbosa, A. A., & Lucato, L. T. (2005). Viral Diseases of the Central Nervous System. Topics in Magnetic Resonance Imaging. https://doi.org/10.1097/01.rmr.0000189108.55275.12
255. Leonardi, R. A., Delalio, E., Spassini, G., & Grassi, V. (2005). Critical illness myopathy and neuropathy (CRI.MY.NE.): un caso clinico in un paziente anziano Critical illness myopathy and neuropathy (CRI.MY.NE.) in the elderly: a case report.
256. Lewis, E. L., & Lawler, K. (2011). Watering flowers in the rain: The elusive nature of executive dysfunction in HIV. Journal of Neurosciences in Rural Practice. https://doi.org/10.4103/0976-3147.80095
257. Li, G., Liu, H., He, Y., Hu, Z., Gu, Y., Li, Y., Ye, Y., & Hu, J. (2022). Neurological Symptoms and Their Associations With Inflammatory Biomarkers in the Chronic Phase Following Traumatic Brain Injuries. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.895852
258. Lim, H.-C., Yu, I.-K., & Oh, K.-S. (2011). Imaging Appearance of Human Immunodeficiency Virus Encephalitis on the Diffusion Weighted Images: A Case Report. Journal of the Korean Society of Radiology. https://doi.org/10.3348/jksr.2011.65.3.207
259. Lin, C., Wang, K., Hsu, L., Lin, K. L., C-P., T., & Shin, C. (2012). Early intravenous immunoglobulin (IVIG) may be effective in severe brainstem-spinal encephalo- myelopathy refractory to steroid suggestive of neuromyelitis optica spectrum disorders.
260. Lin, Y. (2005). Minimally conscious state: definition, diagnostic criteria and clinical features of consciousness disorder. Chinese Journal of Neuromedicine.
261. Llebaria, G., Pagonabarraga, J., Martínez-Corral, M., García‐Sánchez, C., Pascual‐Sedano, B., Gironell, A., & Kulisevsky, J. (2010). Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.23411
262. Locala, J. A. (2010). Depression in the patient with hepatitis C. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511776878.018
263. Loessner, L., Matthes, C., Haußmann, R., Brandt, M., Sauer, C., Espin, M., Noppes, F., Werner, A., Linn, J., Hummel, T., Haehner, A., & Donix, M. (2021). Predictors of subjective cognitive deficits in patients with mild cognitive impairment. Psychogeriatrics. https://doi.org/10.1111/psyg.12802
264. Louzir, B., Msadek, F., Battikh, R., Abdelhafidh, N. B., Harzallah, O., Bekir, S., & Othmani, S. (2004). [Neuro-psychiatric disorders revealed pernicious disease without anemia. About three cases].. PubMed.
265. Luna, A. D., Neto, M., Neto, R. T. D. L., Ferreira, N. B., Adamo, A., Oliveira, G. D., Silva, W. R. D., Sousa, J., Viana, R., Júnior, J. G., Cruz, L. S. D., Neto, C. C. L., Leite, M., & Neto, M. L. R. (2015). Depression as a Risk Factor for HIV Infection rev Iew.
266. Macauley, P., Lamikanra, O., Schiff, C., Kupfer, Y., & MA, S. (2017). Regression: An Atypical Presentation of Lupus Cerebritis. Lupus Open Access. https://doi.org/10.35248/2684-1630.17.2.125
267. Macias, J. E. G. (2015). Desorden neurocognitivo asociado al virus de inmunodeficiencia humana. Ciencia & Futuro.
268. Magner, M. (2019). Clinical Manifestation of Mitochondrial Disorders in Childhood. CRC Press eBooks. https://doi.org/10.1201/9780429443336-21
269. Mahabadi, H. M., Noyce, R. S., Evans, D. H., & Power, C. (2025). Neurological complications of orthopoxvirus infections: neurotropism and neurovirulence. Brain. https://doi.org/10.1093/brain/awaf181
270. Malem, A., Sheth, T., & Muthusamy, B. (2021). Paediatric Idiopathic Intracranial Hypertension (IIH)—A Review. Life. https://doi.org/10.3390/life11070632
271. Mani, J. (2022). Nonconvulsive status epilepticus (NCSE). Bombay Hospital Journal. https://doi.org/10.15713/ins.bhj.77
272. Manji, H., Jäger, H. R., & Winston, A. (2013). HIV, dementia and antiretroviral drugs: 30 years of an epidemic. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2012-304022
273. Marmura, M. J., & Friedman, B. W. (2017). Other Secondary Headaches in the Emergency Department. Cambridge University Press eBooks. https://doi.org/10.1017/9781316819388.007
274. Marquard, K. R., Wörle, H., & Keimer, R. (2004). Hereditary neuropathy with liability to pressure palsies (HNPP) with progressive deafness and demyelination in the central nervous system. Neuropediatrics. https://doi.org/10.1055/s-2004-819435
275. Martelli, M. F., Zasler, N. D., & Grayon, R. (1999). Ethical considerations in medicolegal evaluation of neurologic injury and impairment following acquired brain injury. Neurorehabilitation. https://doi.org/10.3233/nre-1999-13107
276. Matsui, H., Udaka, F., Oda, M., Kubori, T., Nishinaka, K., & Kameyama, M. (2006). Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease. Neurology India. https://doi.org/10.4103/0028-3886.24716
277. Mayer, C., Hackenbroch, C., Mayer, S., Helm, M., & Müller, T. (2022). Hypoxisch-hypoglykämischer Hirnschaden infolge einer Nebennierenrindenkrise – eine wichtige Differenzialdiagnose bei unspezifischer Symptomatik. Die Anaesthesiologie. https://doi.org/10.1007/s00101-022-01088-w
278. McAleese, K. E., Colloby, S. J., Thomas, A., Al‐Sarraj, S., Ansorge, O., Neal, J., Roncaroli, F., Love, S., Francis, P. T., & Attems, J. (2021). Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer s & Dementia. https://doi.org/10.1002/alz.12291
279. McArthur, C., Currie, J., Ramsden, B., Lunch, J., Maruff, P., Benson, E. M., Perdices, M., & Cooper, D. A. (1989). [High-resolution eye movement recording in the assessment of neurologic complications in HIV-1 infection].. PubMed.
280. McArthur, J. C., & Brew, B. J. (2010). HIV-associated neurocognitive disorders: is there a hidden epidemic?. AIDS. https://doi.org/10.1097/qad.0b013e3283391d56
281. McCombe, J. A., Noorbakhsh, F., Buchholz, C., Trew, M., & Power, C. (2009). NeuroAIDS: a watershed for mental health and nervous system disorders.. PubMed.
282. McEntire, C. R. S., Harrold, G. K., & Miller, K. (2025). “I Can’t Concentrate at Work”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197749722.003.0027
283. McGirr, A., Nathan, S., Ghahremani, M., Gill, S., Smith, E. E., & Ismail, Z. (2022). Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. Neurology. https://doi.org/10.1212/wnl.0000000000200256
284. McKeever, A., Cox, A., Garnett, M., & Cunniffe, N. G. (2019). Hydrocephalus as the first presenting symptom of neurosarcoidosis in two patients: a diagnosis more forthcoming in the context of systemic disease. BMJ Case Reports. https://doi.org/10.1136/bcr-2019-229903
285. McLean, L., Aradi, S., Waknin, R., Rea, B., & Camacho, M. A. (2022). HIV-associated dementia presenting predominantly with clinical motor deficits: A case report. Radiology Case Reports. https://doi.org/10.1016/j.radcr.2022.05.076
286. Me, Y., & Th, T. (2006). Febrile encephalopathy: challenges in management.. PubMed.
287. Mehta, Muthukrishnan, J., & Varadarajulu, R. (2003). HIV-associated dementia and caudate atrophy.. PubMed.
288. Meindl, C., Koban, M., Oy, U. H., & Oschmann, P. (2009). Multifocal inflammatory demyelinating neuropathy with GM-1-antibodies and central conduction failure in a marathon runner. Klinische Neurophysiologie. https://doi.org/10.1055/s-0029-1216190
289. Mendes, M. F. S. G., Neto, D. D. C. V., Azevedo, R. A. D., & Caramelli, P. (2012). Narcolepsy after A/H1N1 vaccination. Clinics. https://doi.org/10.6061/clinics/2012(01)12
290. Mesquita, M., & Casartelli, M. (2017). Neonatal hyperbilirubinemia, acute bilirubin encephalopathy and Kernicterus: The conti-nuum is still valid in the 21st century. Pediatría (Asunción). https://doi.org/10.18004/ped.2017.agosto.153-158
291. Meyding‐Lamadé, U., & Craemer, E. M. (2020). Meningitis/Meningoenzephalitis – ein Chamäleon in der Medizin. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1117-6978
292. Meyerowitz, E. A., Sanchez, S., Mansour, M. K., Triant, V. A., & Goldberg, M. B. (2020). Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofaa552
293. Micchìa, K., Formica, C., Salvo, S. D., Muscarà, N., Bramanti, P., Caminiti, F., Marino, S., & Corallo, F. (2022). Normal pressure hydrocephalus. Medicine. https://doi.org/10.1097/md.0000000000028922
294. Miletić, V., & Relja, M. (2009). Dystonia in HIV positive patient.
295. Miller, S. P., & Latal, B. (2009). Neurocognitive outcomes of term infants with perinatal asphyxia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.050
296. Miranda, A. S. D., Queiroz, N. L., Rachid, M. A., & Teixeira, A. L. (2010). Sintomas neurológicos agudos e residuais na malária Acute and residual neurological symptoms in malaria.
297. Mirgh, S., Mishra, V., Harbada, R., & Sorabjee, J. (2019). Knowing the unknown – CD8 encephalitis: A novel form of HIV-associated neurocognitive disorder. Neurology India. https://doi.org/10.4103/0028-3886.253630
298. Miric, D., Nahum, S., Jibidar, H., & Lezy‐Mathieu, A. (2006). VASCULAR PARKINSONISM IN AN ELDERLY WOMAN WITH MIXED CRYOGLOBULINEMIA ASSOCIATED WITH HEPATITIS C INFECTION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2006.00932.x
299. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
300. Mishra, A. K., Anand, R., & Gupta, K. (2017). HIV Presenting as cerebellar ataxia. Journal of Advances in Medicine. https://doi.org/10.5958/2319-4324.2017.00008.6
301. Mitchell, A. J., Kemp, S., Benito‐León, J., & Reuber, M. (2010). The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatrica. https://doi.org/10.1111/j.1601-5215.2009.00439.x
302. Mitchell, W. (2001). Neurological and developmental effects of HIV and AIDS in children and adolescents. Mental Retardation and Developmental Disabilities Research Reviews. https://doi.org/10.1002/mrdd.1029
303. Mitra, P., & Sharman, T. (2020). HIV Neurocognitive Disorders. StatPearls.
304. Mitrajit, S., RK, B., Malakar, J., & IK, S. (2020). Craniocerebral gunshot injury with no neurological deficit: the trending neurosurgical challenge. International Journal of Health Research and Medico Legal Practice. https://doi.org/10.31741/ijhrmlp.v6.i1.2020.16
305. Mohammed, A. P., Koraddi, A., Prabhu, A., Kotian, C. M., & Umakanth, S. (2019). Rapidly progressive dementia with seizures: a post-dengue complication. Tropical Doctor. https://doi.org/10.1177/0049475519885798
306. Moin, A., Prasad, B. N. S., Ramaswamy, S., & Nalloor, S. (2022). Neurosarcoidosis Camouflaging as Partial Miller: Fisher Syndrome. Indian Journal of Rheumatology. https://doi.org/10.4103/injr.injr_148_22
307. Moldovanu, F., Calin, R. B., Nanu, M. I., & Oţelea, M. R. (2020). Late diagnosis of phenylketonuria with p.L48S/p.R408W genotype and late positive response to tetrahydrobiopterin – case presentation and literature review. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7363/090117
308. Mollica, A., Dey, A., Cairncross, M., Silverberg, N. D., & Burke, M. J. (2022). Neuropsychiatric Treatment for Mild Traumatic Brain Injury: Nonpharmacological Approaches. Seminars in Neurology. https://doi.org/10.1055/s-0041-1742143
309. Money, J., & Norman, B. F. (1988). Pedagogical Handicap Associated with Micropenis and Other CHARGE Syndrome Anomalies of Embryogenesis: Four 46, XY Cases Reared as Girls. American Journal of Psychotherapy. https://doi.org/10.1176/appi.psychotherapy.1988.42.3.354
310. Monsalve, W. V., Rodríguez, J. G.-O., & SOLANO, D. M. P. (2014). BULLAS Y NEUMOTORAX ESPONTANEO EN ANOREXIA NERVIOSA REPORTE DE UN CASO Y REVISION DE LA LITERATURA. Acta Médica Colombiana. https://doi.org/10.36104/amc.2014.337
311. Mordecai, M., & Renew, J. R. (2019). Neuroleptic Malignant Syndrome and Hyperthermia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0076
312. Morena, D., Fazio, N. D., Russa, R. L., Delogu, G., Frati, P., Fineschi, V., & Ferracuti, S. (2022). When COVID-19 Is Not All: Femicide Conducted by a Murderer with a Narcissistic Personality “Masked” by a Brief Psychotic Disorder, with a Mini-Review. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph192214826
313. Mukherjee, D., Bhattacharyya, D., Pandit, A., & Dubey, S. (2022). Higher order visual dysfunction and myoclonic-atonic seizure: an atypical presentation of CLN6 neuronal ceroid lipofuscinosis. BMJ Case Reports. https://doi.org/10.1136/bcr-2021-247790
314. Mulder, M., & Geocadin, R. G. (2019). Hypoxic Encephalopathy in the Neurocritical Care Unit. Cambridge University Press eBooks. https://doi.org/10.1017/9781107587908.031
315. Munawar, M., Iftikhar, P. M., Khan, J. A., Syed, N. A., & Syed, T. A. (2019). A Case Report of Seronegative Limbic Encephalitis. Cureus. https://doi.org/10.7759/cureus.4681
316. Møhl, T., & Stenør, C. (2021). Hepatits E virus can cause neurological disorders. Ugeskrift for Læger.
317. Nagure, P., Urunkar, B., Nikam, V., Tiwale, S., & Pawal, S. (2022). Unilateral trigeminal motor nerve neuropathy. Radiology Case Reports. https://doi.org/10.1016/j.radcr.2022.05.074
318. Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-10-142
319. Nakao, S., Miyamoto, E., Yamada, M., Sakamoto, S., Takahashi, M., & Shingu, K. (2006). The aggravation of white matter lesions induced by hypocapnia. Journal of the Japanese Society of Intensive Care Medicine. https://doi.org/10.3918/jsicm.13.125
320. Navia, B., & Price, R. W. (1987). The Acquired Immunodeficiency Syndrome Dementia Complex as the Presenting or Sole Manifestation of Human Immunodeficiency Virus Infection. Archives of Neurology. https://doi.org/10.1001/archneur.1987.00520130051017
321. Navis, A., Jiao, J., George, M. C., Simpson, D. M., & Robinson‐Papp, J. (2017). Comorbid Pain Syndromes in HIV-Associated Peripheral Neuropathy. Pain Medicine. https://doi.org/10.1093/pm/pnx129
322. Ngarka, L., Fodjo, J. N. S., Aly, E., Masocha, W., & Njamnshi, A. K. (2022). The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.803475
323. Nguyễn, Đ. T., & Hương, T. M. (2025). CA LÂM SÀNG HIẾM GẶP: LIỆT DÂY THẦN KINH SỐ III ĐƠN ĐỘC MỘT BÊN LIÊN QUAN ĐẾN SỐT XUẤT HUYẾT DENGUE. Tạp chí Y học Việt Nam. https://doi.org/10.51298/vmj.v546i2.12598
324. Nicholson, W. C., Kempf, M.-C., Moneyham, L., & Vance, D. E. (2017). The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s136065
325. Nielson, K. A., Smith, J. C., Antuono, P., Lyons, J.-A., Hanson, R., Butts, A. M., Hantke, N., & Verber, M. (2013). Semantic Memory Functional MRI and Cognitive Function after Exercise Intervention in Mild Cognitive Impairment. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-130467
326. Noble, J. M. (2022). Less Common Causes of Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0010
327. Noetzel, M. J., & Brunstrom, J. E. (2001). The vulnerable oligodendrocyte. Neurology. https://doi.org/10.1212/wnl.56.10.1254
328. Noguera‐Julián, A., Pérez‐Dueñas, B., Guasch, C. F., Casas, J. A. L., & Argüelles, P. P. (2004). Evolución y tratamiento de la encefalopatía subaguda progresiva por virus de inmunodeficiencia humana en el niño. Utilidad de la toxina botulínica. Revista de Neurología. https://doi.org/10.33588/rn.3803.2003334
329. Nolan, J., & Short, J. A. (1995). Neuroleptic malignant syndrome and hyperosmolar, non‐ketotic hyperglycaemic coma. Practical Diabetes. https://doi.org/10.1002/pdi.1960120316
330. Novikova, M. S. (2020). Prevention of dementia in patients with mild cognitive impairment. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2020120081167
331. NR, R., Yousuf, R., HT, K., Unit, M., Ka, I., & Aziz, A. (2020). Hashimoto’s Encephalopathy Presenting with Acute Behavioral Disturbances: A Case Report. International Journal of Human and Health Sciences (IJHHS). https://doi.org/10.31344/ijhhs.v4i4.219
332. Nunes, T., Fragata, I., Ribeiro, F., Palma, T., Marôco, J., Cannas, J., Secca, M. F., Menezes, C. M., Carmo, I. D., Cunha, G., Castelo‐Branco, M., Guerreiro, M., & Mendonça, A. D. (2010). The Outcome of Elderly Patients with Cognitive Complaints but Normal Neuropsychological Tests. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2010-1210
333. Ogbebor, O., Tariq, S., Jaber, T., Super, J., Bhanot, N., Rana, S., & Malik, K. M. (2022). Neurological Emergencies in the Intensive Care Unit. Critical Care Nursing Quarterly. https://doi.org/10.1097/cnq.0000000000000435
334. Oh, H., Kang, S., Choi, W. A., Lee, J. W., Suh, M. R., & Kim, E. Y. (2017). Motor Neuron Disease Presenting With Acute Respiratory Failure: A Case Study. Annals of Rehabilitation Medicine. https://doi.org/10.5535/arm.2017.41.2.328
335. Okasha, M., & El-Mazary, A.-A. (2019). An image for Deferential Diagnosis. Annals of Neonatology Journal. https://doi.org/10.21608/anj.2019.45820
336. Omoomi, S., & Ghasemi, M. (2025). A Case of Peripheral Nerve Hyperexcitability Syndrome Pretended as Infective Endocarditis: Case Report. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-5791843/v1
337. Ong, L. T. (2021). Psychosis symptoms associated with Niemann-Pick disease type C. Psychiatric Genetics. https://doi.org/10.1097/ypg.0000000000000286
338. Orrell, C., Reid, E., Stoloff, K., & Joska, J. A. (2012). Psychotropic prescribing in HIV. Southern African Journal of HIV Medicine. https://doi.org/10.4102/sajhivmed.v13i4.115
339. Orsini, A., Valetto, A., Bertini, V., Esposito, M., Carli, N., Minassian, B. A., Bonuccelli, A., Peroni, D., Michelucci, R., & Striano, P. (2019). The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy. Seizure. https://doi.org/10.1016/j.seizure.2019.08.012
340. O’Connell, P. G. (1991). Aids. Occupational Therapy In Health Care. https://doi.org/10.1080/j003v07n02_05
341. O’Ferrall, E., Gendron, D., Guiot, M., Hall, J. A., & Sinnreich, M. (2013). Lower motor neuron syndrome due to cauda equina hypertrophy with onion bulbs. Muscle & Nerve. https://doi.org/10.1002/mus.23816
342. Pablos, E. G., Andrés, R. M. S., Villalobos, J. A. L., Polonia, F. F. I. S., Villagrá, G. H., González‐Sanguino, C., & Lorenzo, C. (2019). Pacientes con esquizofrenia de edad avanzada: Deterioro cognitivo y factores relacionados. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
343. Pagnoux, C., & Swartz, R. H. (2017). Vasculitis of the Central Nervous System. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0099
344. Palmer, S. C., Zwieten, A. V., Saglimbene, V., Ruospo, M., & Strippoli, G. F. (2022). Neurocognitive Disorders. https://doi.org/10.1002/9781119105954.ch75
345. Parker, J. R., Parker, J. C., & Overman, J. C. (1990). Intracranial diffuse axonal injury at autopsy.. PubMed.
346. Parkes, J. D., Jenner, P., Rushton, D. N., & Marsden, C. D. (1987). Drug Treatment of Infections of the Nervous System. Treatment in clinical medicine. https://doi.org/10.1007/978-1-4471-3140-3_6
347. Parkes, J. D., Jenner, P., Rushton, D. N., & Marsden, C. D. (1987). Treatment of Disorders Involving the Autonomic Nervous System. Treatment in clinical medicine. https://doi.org/10.1007/978-1-4471-3140-3_10
348. Patchner, L. S., & DeWeaver, K. L. (2013). Disability: Neurocognitive Disabilities. Encyclopedia of Social Work. https://doi.org/10.1093/acrefore/9780199975839.013.542
349. Patel, S. M., Mehta, V. V., Jekaliya, K. V., & Boghani, A. R. (2022). A CASE REPORT OF PEDIATRIC MOG- ANTIBODY DISEASE WITH BILATERAL OPTIC NEURITIS. PARIPEX-INDIAN JOURNAL OF RESEARCH. https://doi.org/10.36106/paripex/3901261
350. Pedroza-García, K. A., Calderón-Vallejo, D., & Quintanar, J. L. (2022). Neonatal Hypoxic–Ischemic Encephalopathy: Perspectives of Neuroprotective and Neuroregenerative Treatments. Neuropediatrics. https://doi.org/10.1055/s-0042-1755235
351. Pennisi, M., Bramanti, A., Cantone, M., Pennisi, G., Bella, R., & Lanza, G. (2017). Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2017.00498
352. Perera, B., McCarthy, J., & Courtenay, K. (2022). Assessing and managing attention-deficit hyperactivity disorder in people with intellectual disability. BJPsych Advances. https://doi.org/10.1192/bja.2022.23
353. Perry, S. W. (1990). Organic mental disorders caused by HIV: update on early diagnosis and treatment. American Journal of Psychiatry. https://doi.org/10.1176/ajp.147.6.696
354. Perry, S. W. (1993). Depression and HIV How Does One Affect the Other?. JAMA. https://doi.org/10.1001/jama.1993.03510210095036
355. Person, C., Atkinson, J. H., Young, C., Deitch, D. A., & Treisman, G. J. (2005). Psychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0048
356. Peterson, K. S. (2006). Musculoskeletal and autoimmune manifestations of non-rheumatic disorders. https://doi.org/10.1093/oso/9780192632920.003.0010
357. Peyro‐Saint‐Paul, L. (2010). COLITES ISCHEMIQUES ET NEUROLEPTIQUES. Editions universitaires europeennes eBooks.
358. Peyser, J. M. (2009). Experience in cognitive assessment in MS relevant to developing a simple rating system. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1984.tb02547.x
359. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELATIONSHIP BETWEEN SLEEP QUALITY, BODY PERCEPTION AND MOTOR AND SENSORY SYMPTOMS IN PEOPLE WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS. Aracê.. https://doi.org/10.56238/arev7n8-155
360. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
361. Pies, R. W. (2017). The Astonishing Non-Epidemic Continues--With a Red Flag on the Field.
362. Piper, K. P. K. S. N. (1998). Critical Illness Polyneuropathy Following Cardiac Surgery. Scandinavian Cardiovascular Journal. https://doi.org/10.1080/14017439850139933
363. Plaut, T., & Weiss, J. M. (2021). Electrodiagnostic Evaluation Of Critical Illness Neuropathy. StatPearls.
364. Polster, T., Jamra, R. A., Sticht, H., & Woermann, F. G. (2021). Pathogenic Variants in SCN2A Are Associated with Severe Developmental and Epileptic Encephalopathy with Bilateral Polymicrogyria and Incomplete Opercularization. Neuropediatrics. https://doi.org/10.1055/s-0041-1739618
365. Popović, D. B., & Sinkjær, T. (2013). Diseases and Injuries of the Central Nervous System Leading to Sensory–Motor Impairment. https://doi.org/10.1002/9781118628522.ch1
366. Poutiainen, E., Haltia, M., Elovaara, I., Lähdevirta, J., & Livanainen, M. (1991). Dementia associated with human immunodeficiency virus: subcortical or cortical?. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05543.x
367. Power, C., Lomax, L. B., Rourke, S. B., & Gill, M. J. (2009). NeuroAIDS: An Evolving Epidemic. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100007009
368. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
369. Pramesti, F. A., Husna, M., Kurniawan, S. N., & Rahayu, M. (2017). DIAGNOSIS AND MANAGEMENT OF NONCONVULSIVE STATUS EPILEPTICUS (NCSE). MNJ (Malang Neurology Journal). https://doi.org/10.21776/ub.mnj.2017.003.01.6
370. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
371. Pridmore, S., McInerney, G. M., Rybak, M., & Archer, S. (2006). Psychotic disorder NOS with heterotopia. Journal of Psychiatric Intensive Care. https://doi.org/10.1017/s1742646407000386
372. Priftis, K., Algeri, L., Villella, S., & Spada, M. S. (2020). COVID-19 presenting with agraphia and conduction aphasia in a patient with left-hemisphere ischemic stroke. https://doi.org/10.31219/osf.io/ku9jw
373. Prigatano, G. P., Hendin, B., & Heiserman, J. E. (2014). Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2014.890700
374. Provini, F., Lombardi, C., & Lugaresi, E. (2005). Insomnia in Neurological Diseases. Seminars in Neurology. https://doi.org/10.1055/s-2005-867074
375. Puccioni‐Sohler, M., Alvarenga, R. M. P., Souza, P. M. D., França, S. C. D., Gonçalves, R. R., & Jacobson, S. (2005). Parkinsonism in the course of HTLV‐I‐associated myelopathy. Movement Disorders. https://doi.org/10.1002/mds.20402
376. Punsoni, M., Neder, L., Plu, I., & Anthony, D. C. (2025). Acquired Metabolic Diseases of the Nervous System. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197661307.003.0009
377. Pupo, J. M. R., Rojas, Y. V. D., Borrego, U. C., Díaz, M. D. C. G., & García, S. M. (2012). Presentación de un paciente con encefalomielitis difusa aguda. Correo Científico Médico.
378. Rado, J. (2017). Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C. Psychiatric Annals. https://doi.org/10.3928/00485713-20161201-01
379. Rajendran, M., Rajasekaran, D., & Chandrasekar, S. (2006). Drug related crisis in myasthenia gravis.. Journal of the Association of Physicians of India.
380. Rasalkar, D. D., & Chu, C. W. (2012). Imaging in children presenting with acute neurological deficit: paediatric stroke mimics. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2011-130088
381. Raunio, F., Kelppe, J., & Hafrén, L. (2022). Malignant lymphoma presenting as bilateral sensorineural hearing loss—A case report. Clinical Case Reports. https://doi.org/10.1002/ccr3.6711
382. Retzlaff, C. (1999). Speech and language pathology & pediatric HIV.. PubMed.
383. Rhee, J. Y., Torun, N., Neilan, T. G., & Guidon, A. C. (2022). Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms. The Oncologist. https://doi.org/10.1093/oncolo/oyac033
384. Ribeiro, R. T., Pinto, M. M. P., Villa, T. R., Gamba, L. T., Tengan, C. H., & Souza-Carvalho, D. D. (2009). Migrainous infarction as a complication of sporadic hemiplegic migraine in childhood. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2009000500026
385. Rieder, C. R. D. M., & Ziomkowski, S. (2005). Head tremor and progressive multifocal leukoencephalopathy in AIDS patients: report of two cases. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2005000100027
386. Riordan, S. M., & Williams, R. R. (2010). Gut Flora and Hepatic Encephalopathy in Patients with Cirrhosis. New England Journal of Medicine. https://doi.org/10.1056/nejme1000850
387. Rizki, M. F., Sugianto, P., Maramis, M. M., & Soetjipto, S. (2022). Viral Meningoencephalitis Patient with Comorbid Major Depression with Psychotic Symptoms: A Case Report. Pharmacognosy Journal. https://doi.org/10.5530/pj.2022.14.121
388. Rm, L., De, B., & Ml, R. (1990). Neurologic complications of HIV infection.. PubMed.
389. Rocha, F. L., Caramelli, P., & Oliveira, L. C. (2012). Complex visual hallucinations and delusional infestation comorbidity. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2012000700017
390. Rocha, L. D., Lima, H. D. L. D., Correia, R., Freitas, M., Melo, P. D., Mattos, A. D., Oliveira, A. D., Marques, C., Duarte, Â., Lins, O. G., & Ranzolin, A. (2017). SAT0566 Electroneurographic findings in patients with subacute/chronic articular symptoms of chikungunya fever and neuropathic complaints – preliminary results. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-eular.5554
391. Rodriguez, A. M. T., Díaz, A., Ruíz, D. P., & Prada, B. L. (2019). Fulminant Progressive Brainstem Encephalitis as Initial Manifestation of NeuroBechet's Disease. International Journal of Rare Diseases & Disorders. https://doi.org/10.23937/2643-4571/1710012
392. Rodriguez, W. A. A., Franco, R. G., Lugo, A. L. C., Meneses, M. M. N., & Ortega, Y. L. Á. (2020). Evolución y secuelas cognitivas en un paciente con encefalopatía por VIH/SIDA con tratamiento antirretroviral. Revista chilena de neuropsicología.
393. Rogan, W. J., Dietrich, K. N., Ware, J. H., Dockery, D. W., Salganik, M., Radcliffe, J., Jones, R. L., Ragan, N. B., Chisolm, J. J., & Rhoads, G. G. (2001). The Effect of Chelation Therapy with Succimer on Neuropsychological Development in Children Exposed to Lead. New England Journal of Medicine. https://doi.org/10.1056/nejm200105103441902
394. Ronca, S. E., Smith, J. N., Koma, T., Miller, M. M., Yun, N. E., Dineley, K. T., & Paessler, S. (2017). Mouse Model of Neurological Complications Resulting from Encephalitic Alphavirus Infection. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.00188
395. Rosas, S. P. M. (2013). LA HIPOTONÍA EN EL RECIÉN NACIDO, UN SIGNO CLAVE PARA EL PRONÓSTICO NEUROLÓGICO.
396. Rosenberg, R. N. (2004). Foreword. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545054.001
397. Rowbotham, M. C. (2005). Is fibromyalgia a neuropathic pain syndrome?. PubMed.
398. Rubin, D. I., & Daube, J. R. (1999). Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle & Nerve. https://doi.org/10.1002/(sici)1097-4598(199911)22:11<1607::aid-mus21>3.0.co;2-j
399. Rubin, L. H., Springer, G., Martin, E., Seaberg, E. C., Sacktor, N., Levine, A. J., Valcour, V., Young, M., Becker, J. T., & Maki, P. M. (2019). Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000002029
400. Rupprecht, S., Kallweit, U., & Bergmeier, C. (2017). Beatmung bei neurologischen Erkrankungen. Schlaf. https://doi.org/10.1055/s-0038-1626173
401. Sacktor, N. (1998). Psychiatric issues and human immunodeficiency virus-associated dementia. Medical Update for Psychiatrists. https://doi.org/10.1016/s1082-7579(98)00027-2
402. Sacktor, N. C. (2003). Advances in the treatment of HIV dementia.. PubMed.
403. Sadek, J., Pergam, S. A., Harrington, J., Echevarria, L., Davis, L. E., Goade, D., Harnar, J., Nofchissey, R. A., Sewell, C. M., Ettestad, P., & Haaland, K. Y. (2009). Persistent neuropsychological impairment associated with West Nile virus infection. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390902881918
404. Sankowska, M., Janicka, J., & Stanosz-Sankowska, M. J. (2020). Kleine–Levin syndrome – a diagnostic challenge? Case report. Aktualności Neurologiczne. https://doi.org/10.15557/an.2020.0023
405. Saraiva, R., Gonçalves, A. S. D. S., Sereijo, C., Castanheira, L. N., Cordeiro, C., Côrte‐Real, B., Queirós, T. P., Barandas, R., Coentre, R., & Abreu, M. (2019). A CASE OF NON ALCOHOLIC WERNICKE KORSAKOFF SYNDROME RESULTING FROM MALNUTRITION DUE TO PSYCHOSIS. https://doi.org/10.26226/morressier.5d1a037357558b317a14038c
406. Sato, D. K., & Souza, R. B. D. (2017). Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20170056
407. Scarpino, M., Lolli, F., Lanzo, G., & Grippo, A. (2020). What is the Role of Post Acute EEG in Prediction of Late Neurological Outcome in Severe Disorders of Consciousness?. Future Neurology. https://doi.org/10.2217/fnl-2019-0017
408. Schaefer, M., Sarkar, R., & Díez, C. (2013). Management of Mental Health Problems Prior to and During Treatment of Hepatitis C Virus Infection in Patients With Drug Addiction. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit266
409. Schafernak, K. T., & Bigio, E. H. (2006). West Nile Virus Encephalomyelitis with Polio-like Paralysis &amp; Nigral Degeneration. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100005370
410. Scheau, C., Popa, G. A., Ghergus, A. E., Preda, E. M., Capsa, R. A., & Lupescu, I. G. (2013). Persistent repeated measurements by magnetic resonance spectroscopy demonstrate minimal hepatic encephalopathy: a case report.. PubMed.
411. Schiffmann, R., & Knaap, M. S. V. D. (2009). Invited Article: An MRI-based approach to the diagnosis of white matter disorders. Neurology. https://doi.org/10.1212/01.wnl.0000343049.00540.c8
412. Schmidt, U., & Miller, D. S. (1988). Two Cases of Hypomania in AIDS. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.152.6.839
413. Sciolla, A. (1995). Sleep disturbance and HIV disease.. PubMed.
414. Scott, H., Martí, J., & Witte, P. (2022). Neuromuscular Disorders. CRC Press eBooks. https://doi.org/10.1201/9780429091537-35
415. Seo, Y., Reed, M., Chang, J. S., & Lui, F. (2022). Wernicke’s Encephalopathy Presenting With Confusion in a Patient With Schizophrenia. Cureus. https://doi.org/10.7759/cureus.32320
416. Seong, M. J., & Hong, S. B. (2017). Autoimmunity and Immunotherapy in Narcolepsy. Sleep Medicine Research. https://doi.org/10.17241/smr.2017.00052
417. Sharifian, M., Khalili, M. R., Nomovi, M., & Dorche, A. S. (2017). Leber Hereditary Optic Neuropathy Plus: A Case Report and Review of Literatures. Internal Medicine And Medical Investigation Journal. https://doi.org/10.24200/imminv.v2i3.67
418. Sharma, N., & Kolekar, H. M. (2017). Diagnosis of Vascular Cognitive Impairment Using EEG. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00454.5
419. Shevell, M., Rosenblatt, B., Silver, K., Carpenter, S., & Karpati, G. (1990). Congenital inflammatory myopathy. Neurology. https://doi.org/10.1212/wnl.40.7.1111
420. Shi, J., Niu, J., Shen, D., Li, Y., Liu, M., Tan, Y. K., Cui, L., Guan, Y., & Zhang, L. (2019). [Clinical Diagnosis and Treatment Recommendations for Adverse Reaction in the Nervous System Related to Immunocheckpoint Inhibitor].. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.3779/j.issn.1009-3419.2019.10.05
421. Shi, J., Niu, J., Shen, D., Liu, M., Tan, Y. K., Li, Y., Huang, Y.-Y., Cui, L., Guan, Y., & Zhang, L. (2019). Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related adverse reactions in the nervous system. Thoracic Cancer. https://doi.org/10.1111/1759-7714.13266
422. Shirai, K., Nakajima, K., Watanabe, A., Kawano, Y., Sakuma, H., Yoshida, T., Miyata, R., Tanuma, N., & Hayashi, M. (2009). [Fulminating meningitis caused by Haemophilus influenzae with rapid progression of severe brain edema similar to acute encephalopathy].. PubMed.
423. Shore, T. B., Barnett, M. J., & Phillips, G. L. (1990). Sudden neurologic death after intrathecal methotrexate. Medical and Pediatric Oncology. https://doi.org/10.1002/mpo.2950180213
424. Shukla, R., Desai, P., Mehta, H. K., & Bajpai (2006). Myoclonic Ataxia as Presenting Manifestation of HIV Infection. Annals of Neurosciences. https://doi.org/10.5214/158
425. Siahaan, A. M. P., Tandean, S., Indharty, R. S., Nainggolan, B. W. M., & Susanto, M. (2022). Paroxysmal sympathetic hyperactivity syndrome in tuberculous meningitis with paradoxical reaction. International Journal of Surgery Case Reports. https://doi.org/10.1016/j.ijscr.2022.107619
426. Silva, F. A., Salgado, S. A., Rodriguez, V. T., Ruiz, N., Ocampo, M., Prada, J., & Amaya, C. I. (2013). Hidrocefalia y aracnoiditis en neurocisticercosis Hydrocephalus and arachnoiditis in neurocysticercosis.
427. Singh, G., Murthy, J. M. K., & Radhakrishnan, A. (2012). Epilepsy due to Traumatic Brain Injury, Cerebrovascular Disease, Central Nervous System Infections, and Brain Tumours. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199659043.003.0020
428. Singh, O. P., Sarkhel, S., & Sarkar, S. (2022). Management of Psychiatric Disorders with HIV and Dermatological Disorders. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_14_22
429. Sisalema, U., & Verónica, C. (2017). Análisis de esclerosis múltiple mas Ptosis Palpebral enfocado con la atención de enfermería.
430. Slomka, G. T., Bailey, D., Ammerman, R. T., Reigel, D. H., & Kane, V. (1997). ADHD vulnerability in children with Spina Bifida and Hydrocephaly. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/12.4.405
431. SM, X. D., ROY, C. L., Rebollo, M. J., Moraga, F., & Castillo‐Durán, C. (2010). Nutrición del Niño con Enfermedades Neurológicas Prevalentes: An Update. Revista chilena de pediatría. https://doi.org/10.4067/s0370-41062010000200002
432. Snowden, J. S., Craufurd, D., Griffiths, H. L., & Neary, D. (1998). Awareness of Involuntary Movements in Huntington Disease. Archives of Neurology. https://doi.org/10.1001/archneur.55.6.801
433. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
434. Sonneville, R., Klein, I., Broucker, T. D., & Wolff, M. (2009). Post-infectious encephalitis in adults: Diagnosis and management. Journal of Infection. https://doi.org/10.1016/j.jinf.2009.02.011
435. Sonneville, R., Verdonk, F., Rauturier, C., Klein, I., Wolff, M., Annane, D., Chrétien, F., & Sharshar, T. (2013). Understanding brain dysfunction in sepsis. Annals of Intensive Care. https://doi.org/10.1186/2110-5820-3-15
436. Sousa, L. C., Coelho, T., & Taipa, R. (2021). CNS Involvement in Hereditary Transthyretin Amyloidosis. Neurology. https://doi.org/10.1212/wnl.0000000000012965
437. Stanic, A. K., Sretenovic, S., Culafic, D., Smiljković, T., Sujic, R., Malovic, J., Kostić, S., & Mitrović, A. (2013). Lyme neuroborreliosis: Encephalopathy as a clinical form of the disease. PONS - medicinski casopis. https://doi.org/10.5937/pons1304166s
438. Steens, S. C. A. (2006). Magnetic Resonance Imaging studies on neuropsychiatric systemic lupus erythematosus.
439. Stevens, R. D., Sharshar, T., & Ely, E. W. (2013). Diagnosis of Brain Dysfunction. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139248822.026
440. Stiles, K. A., Weisbach, E., & Cahill, J. (2022). Neurological Sequelae of COVID-19 in Rehabilitation Settings.. PubMed.
441. Stinton, L. M., & Jayakumar, S. (2013). Minimal Hepatic Encephalopathy. Canadian Journal of Gastroenterology. https://doi.org/10.1155/2013/547670
442. Studahl, M., & Sköldenberg, B. (2017). Herpes Simplex Encephalitis and Other Neurological Syndromes Caused by Herpes Simplex Virus-1. CRC Press eBooks. https://doi.org/10.1201/9780203711828-11
443. Su, J.-J., Chiu, M., & Chang, Y. (2003). Coexistence of Epilepsy and Myasthenia Gravis: Report of Four Patients and Review of the Literature. Acta Neurologica Taiwanica.
444. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
445. Sumner, J., Noack, C. G., Filoteo, J. V., Maddox, W. T., & Saxena, S. (2015). Neurocognitive performance in unmedicated patients with hoarding disorder.. Neuropsychology. https://doi.org/10.1037/neu0000234
446. Swingler, S. (1997). Pathogenic mechanisms of neuronal damage in the AIDS dementia complex.. Molecular Pathology. https://doi.org/10.1136/mp.50.2.72
447. Sánchez, E. C. J., Correa‐Díaz, E. P., Martínez-Burbano, B., Yepez, M., & Castillo, M. A. G. (2017). Neurocysticercosis a public health problem. Clinical Case Reports. https://doi.org/10.1002/ccr3.873
448. Sсhugareva, L. M., Poteshkina, O. V., Kruchina, M. K., & Rusak, M. A. (2019). Fever-induced epileptic encephalopathy in children (FIRES). HERALD of North-Western State Medical University named after I I Mechnikov. https://doi.org/10.17816/mechnikov201810465-72
449. Takagaki, K., Morales, M. K., Vitantonio, D., Berkowitz, F. E., Bell, W. L., Kumar, P., & Motamedi, G. K. (2014). Periodic Lateralized Epileptiform Discharges (PLEDs) in Patients With Neurosyphilis and HIV Infection. Clinical EEG and Neuroscience. https://doi.org/10.1177/1550059414552704
450. Talasman, A.-A., Dolfi, A., & Nae, M. (2017). Acute psychotic episode in a patient with HIV encephalopathy. Romanian Journal of Psychiatry & Psychotherapy. https://doi.org/10.37897/rjpp.2017.2.8
451. Talasman, A.-A., Dolfi, A., & Nae, M. (2017). Acute psychotic episode in a patient with HIV encephalopathy. Romanian Journal of Psychiatry & Psychotherapy. https://doi.org/10.37897/rjpp.2017.8
452. Tan, C., & Reeves, R. K. (2021). HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?. AIDS. https://doi.org/10.1097/qad.0000000000002957
453. Tan, C., Zhong, M., Yao, Z., Hong, S., Jiang, L., & Jiang, Y. (2022). Anti-GFAP Antibody-Associated Hypertrophic Pachymeningitis. Neuropediatrics. https://doi.org/10.1055/s-0042-1742718
454. Tankişi, H., Carvalho, M. D., & Z’Graggen, W. J. (2020). Critical Illness Neuropathy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0000000000000658
455. Tanner, B. A. (1988). Psychological aspects of hypohidrotic ectodermal dysplasia.. PubMed.
456. Tassi, A., Gitto, S., Piras, C., Cursaro, C., Alicandro, T., Margotti, M., Rivi, M., & Andreoné, P. (2021). Cognitive, neurological and psychiatric disorders occurring in Hepatitis C Virus infection. Minerva Medica. https://doi.org/10.23736/s0026-4806.21.07388-2
457. Tazrout, D., Bouchal, S., Alami, B., Maaroufi, M., & Belahsen, F. (2025). Myélinolyse centropontine secondaire à une hyperglycémie sans cétose. https://doi.org/10.70780/medpeer.000qgni
458. Te, S., & Hu, F. (1988). [HIV infection of the central nervous system: psychiatric consequences].. PubMed.
459. Terán, J. D. D., & Membrilla, J. A. (2022). Síndrome HaNDL. Kranion. https://doi.org/10.24875/kranion.m22000025
460. Thada, S. R., Gadda, R. B., & Pai, K. M. (2013). Nerve afflictions of maxillofacial region: a report of two cases. BMJ Case Reports. https://doi.org/10.1136/bcr-2013-201002
461. Thakurathi, N., & Henderson, D. C. (2012). Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder. Evidence-Based Mental Health. https://doi.org/10.1136/ebmental-2012-100740
462. Theoharides, T. C., Cholevas, C., Polyzoidis, K. S., & Politis, A. (2021). Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue. BioFactors. https://doi.org/10.1002/biof.1726
463. Thompson, A. J., Williams, D. R., Freudenreich, O., Angelino, A. F., & Treisman, G. J. (2017). Psychotic Disorders and Serious Mental Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199392742.003.0019
464. Tiplamaz, S., Beygirci, A., Arslan, M. N., & İnanıcı, M. A. (2020). Abusive head trauma: two cases and mini-review of the current literature. The Turkish Journal of Pediatrics. https://doi.org/10.24953/turkjped.2020.05.023
465. Tizenberg, B., Brenner, L. A., Lowry, C. A., Okusaga, O., Benavides, D. R., Hoisington, A. J., Benros, M. E., Stiller, J. W., Kessler, R. C., & Postolache, T. T. (2021). Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19. Current Psychiatry Reports. https://doi.org/10.1007/s11920-021-01275-3
466. Toapanta‐Yanchapaxi, L., López‐Velázquez, J. A., Uribe, M., & Méndez‐Sánchez, N. (2013). Minimal hepatic encephalopathy. Should we treat it?. Annals of Hepatology. https://doi.org/10.1016/s1665-2681(19)31013-0
467. Toro, J. (2013). Rivastigmine for HIV-Associated Neurocognitive Disorders?. Journal watch. https://doi.org/10.1056/jn201302190000001
468. Torres, O. T., Martínez, H., Mm, M., Palermo, C., Figueroa, C. V., Santiago, M. F., Mde, M., & González, E. D. O. (2013). Hashimoto's encephalopathy: an underdiagnosed clinical entity.. PubMed.
469. Torrico, T., Kiong, T., D’Assumpcao, C., Aisueni, U., Jaber, F., Sabetian, K., Molla, M. A. R., Kuran, R., & Heidari, A. (2021). Postinfectious COVID-19 Catatonia: A Report of Two Cases. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.696347
470. Treisman, G. J. (2006). THE "TRIPLE-THREAT" PATIENT: PSYCHIATRIC PROBLEMS, SUBSTANCE ABUSE DISORDERS, AND HIV *. Advanced studies in medicine.
471. Tripathi, M., & Vibha, D. (2009). Reversible dementias.. PubMed.
472. Tudorache, E., Marc, M., Trăilă, D., & Manolescu, D. (2020). Cognitive Impairment in Chronic Lung Diseases. IntechOpen eBooks. https://doi.org/10.5772/intechopen.91825
473. Turner, R. S., Chervin, R. D., Frey, K. A., Minoshima, S., & Kuhl, D. (1997). Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology. https://doi.org/10.1212/wnl.49.2.523
474. Ullah, W., Cheema, M. A., Ashfaq, A., Mukhtar, M., Ali, Z., Rashid, M. U., & Figueredo, V. M. (2020). A rare association of Takotsubo cardiomyopathy with neuroleptic malignant syndrome. Journal of Community Hospital Internal Medicine Perspectives. https://doi.org/10.1080/20009666.2020.1742522
475. Uziel, G., Savoiardo, M., Strada, L., Ciceri, E., Antozzi, C., & Zeviani, M. (1992). La risonanza magnetica nelle encefalomiopatie mitocondriali. Rivista di Neuroradiologia. https://doi.org/10.1177/19714009920050s105
476. Vance, D. E. (2013). The Cognitive Consequences of Stigma, Social Withdrawal, and Depression in Adults Aging with HIV. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20130315-01
477. Varelas, P. N., & Jones, M. (2017). Antiepileptic Drugs in the Neurosurgical Intensive Care. Current Pharmaceutical Design. https://doi.org/10.2174/1381612823666171030150437
478. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
479. Vermeulen, G., Seidl, R., Mercimek‐Mahmutoglu, S., Rotteveel, J. J., Scheper, G. C., & Knaap, M. S. V. D. (2005). Fright is a provoking factor in vanishing white matter disease. Annals of Neurology. https://doi.org/10.1002/ana.20418
480. Vinters, H. V. (2004). Infectious (and inflammatory) diseases causing dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511526886.022
481. Wali, S., Mithilesh, S., Sheikh, C., Parihar, A. S., & Ganachari, G. M. (2019). A Rare Case Report: Leigh Syndrome. Indian Journal of Pharmacy Practice. https://doi.org/10.5530/ijopp.12.4.59
482. Walker, M. C. (2005). Treatment of non-convulsive status epilepticus.
483. Walker, M., Hall, K. S., Peppercorn, K., & Tate, W. P. (2022). The significance of oxidative stress in the pathophysiology of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medical Research Archives. https://doi.org/10.18103/mra.v10i9.3050
484. Weisberg, L. A. (2001). Neurologic Abnormalities in Human Immunodeficiency Virus Infection. Southern Medical Journal. https://doi.org/10.1097/00007611-200194030-00001
485. Weißenborn, K. (2019). Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs. https://doi.org/10.1007/s40265-018-1018-z
486. Welk, B., Sakakibara, R., Sinha, S., Haslam, C., Vrijens, D., Gomes, C. M., Wachter, S. D., Konstantinidis, C., Popolo, G. D., Vasudeva, P., Drake, M. J., & Hamid, R. (2022). Lower urinary tract dysfunction in uncommon neurological diseases: A report of the neurourology promotion committee of the International Continence Society. Continence. https://doi.org/10.1016/j.cont.2022.100022
487. Weston, A., Weinstein, A. M., Barton, C., & Yaffe, K. (2009). Potentially Inappropriate Medication Use in Older Adults With Mild Cognitive Impairment. The Journals of Gerontology Series A. https://doi.org/10.1093/gerona/glp158
488. Wheeler, P. G., Huang, D., & Dai, Z. (2014). Haploinsufficiency of HDAC4 does not cause intellectual disability in all affected individuals. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.36542
489. Wiels, W., Boudiba, Y., Seynaeve, L., & Raedt, S. D. (2022). Anti-NMDA-receptor encephalitis: an unusual treatable cause of chronic insomnia?. PubMed. https://doi.org/10.5935/1984-0063.20200080
490. Wijdicks, E. F. M. (2001). Seizures in the Intensive Care Unit. https://doi.org/10.1093/oso/9780195140798.003.0003
491. Wijdicks, E. F. M. (2025). Acute Encephalitis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0038
492. Wint, D., & Cummings, J. L. (2013). Comorbid Neurological Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199796816.003.0017
493. Wolff, M., Sonneville, R., & Sharshar, T. (2020). Clinical Approach to the Adult Patient with CNS Infection. https://doi.org/10.1002/9781119467748.ch4
494. Wolff, M., Wolff, C., & Alvarado, R. (2010). Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH: Revisión de la literatura. Revista chilena de infectología. https://doi.org/10.4067/s0716-10182010000100011
495. Wu, J., Luo, X., Huang, N., Li, Y., & Luo, Y. (2022). Misdiagnosis of HIV With Toxoplasmosis Encephalopathy With Progressive Memory Loss as the Initial Symptom: A Case Report. Frontiers in Neurology. https://doi.org/10.3389/fneur.2022.809811
496. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
497. Yang, C., Su, T., Wong, W., Guo, W., & Su, Y.-L. (2005). Association of AIDS and Bipolar Mania with Rapid Progression to Dementia and Death. Journal of the Chinese Medical Association. https://doi.org/10.1016/s1726-4901(09)70142-x
498. Yang, T., Guo, R., Ofengeim, D., Hwang, J.-Y., Zukin, R. S., Chen, J., & Zhang, F. (2021). Molecular and Cellular Mechanisms of Ischemia-Induced Neuronal Death. Stroke. https://doi.org/10.1016/b978-0-323-69424-7.00005-3
499. Yi, T. I., Kim, B. R., Han, I. S., & Kim, B. K. (2013). Motor Axonal Neuropathy Associated With Idiopathic CD4+T-Lymphocytopenia. Annals of Rehabilitation Medicine. https://doi.org/10.5535/arm.2013.37.1.127
500. Yoneda, M., & Matsunaga, A. (2017). II. Hashimto's Encephalopathy. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.106.1550
501. Yung, I. O., Baudendistel, T. E., & Dhaliwal, G. (2013). A Diagnosis of Exclusion. https://doi.org/10.1002/9781118483206.ch19
502. Yvorra, S. P., & Arratibel, A. G. (2022). Episodios "stroke-like", crisis epilépticas y alteraciones metabólicas, a propósito de 1 caso clínico. Neurorecordings. https://doi.org/10.26429/nr-6338
503. Zackariah, N. M., Sreeni, S., & Lakshmi, R. (2017). A Case Report: Morvan's Syndrome. Research Journal of Pharmacy and Technology. https://doi.org/10.5958/0974-360x.2017.00212.8
504. Zahr, N. M., Pohl, K. M., Pfefferbaum, A., & Sullivan, E. V. (2019). Central Nervous System Correlates of “Objective” Neuropathy in Alcohol Use Disorder. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.14162
505. Zajkowska, J., Hermanowska-Szpakowicz, T., Pancewicz, S., Kondrusik, M., & Grygorczuk, S. (2006). Opryszczkowe zapalenie mózgu herpes simplex-encephalitis. Polski Przegląd Neurologiczny.
506. Zajkowska, J., Pancewicz, S. A., & Hermanowska-Szpakowicz, T. (1998). [Neurologic borreliosis].. PubMed.
507. Zarate, N., Gundry, K., Yu, D., Casby, J., Eberly, L. E., Öz, G., & Gómez‐Pastor, R. (2022). Neurochemical correlates of synapse density in a Huntington's disease mouse model. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15714
508. Zhang, M., Zhao, L., & Silveira, P. C. L. (2025). Neuroprotective Effects of Low-Intensity Pulsed Ultrasound in Chronic Traumatic Encephalopathy Induced by Repetitive Head Collisions: A Narrative Review. Biology. https://doi.org/10.3390/biology14091148
509. Zhang, Y., Zheng, Y., Cai, M., Wu, L., & Zhang, B. (2019). Moyamoya disease presenting as thalamic infarction in a patient with neuromyelitis optica spectrum disorder. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.13106
510. Zhao, S., & Wang, T. (2022). [Progress in the diagnosis of minimal hepatic encephalopathy].. PubMed. https://doi.org/10.3760/cma.j.cn501113-20200605-00294
511. Zis, P., & Hadjivassiliou, M. (2019). Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease. Current Treatment Options in Neurology. https://doi.org/10.1007/s11940-019-0552-7
512. Zunt, J. R., Tu, R., Anderson, D., Copass, M. C., & Marra, C. M. (1997). Progressive multifocal leukoencephalopathy presenting as human immunodeficiency virus type 1 (HIV)-associated dementia. Neurology. https://doi.org/10.1212/wnl.49.1.263
513. Špatenková, V., Kazda, A., & Suchomel, P. (2009). Hypernatraemia in the neurointensive care unit: central diabetes insipidus and noncentral diabetes insipidus. Critical Care. https://doi.org/10.1186/cc7618
514. Štrkalj-Ivezić, S., & Mužinić, L. (2006). [Have we forgotten neurological diseases with psychological symptoms? Case study: Huntington's chorea].. Medicinski arhiv.